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Resumo 
 
O peptidoglicano (PGN) bacteriano tem sido associado a infecções bacterianas e à 
resistência antibióticos.  Desta forma, este trabalho surge no enquadramento do problema 
com qual a comunidade científica se tem vindo a deparar aquando da obtenção de 
fragmentos de peptidoglicano puros e em quantidade que permita a realização de estudos 
biológicos. A síntese de fragmentos de PGN é complexa e envolve inúmeros passos de 
síntese e o seu isolamento e purificação de fontes naturais é difícil.  
 Este trabalho consistiu em investigar uma estratégia que permitisse transformar um 
produto considerando um desperdício da indústria alimentar, quitosano, num produto 
valioso, mureina, um polímero de unidades alternadas de NAG-NAM que se encontram 
interligadas por pontes peptídicas. Para isso explorou-se uma aproximação 
quimioenzimática. Numa primeira estratégia procedeu-se à protecção regioselectiva dos 
grupos hidroxilo da posição O-6 com dois grupos, TBDPS e TPS, com consequentemente 
introdução da unidade lactil na posição O-3, apenas contando com o impedimento estéreo 
que estes grupos proporcionavam à entrada do grupo lactil.  
 Numa segunda estratégia, foi utilizado uma pinça molecular, “molecular clamp”, 
com vista a forçar uma entrada da unidade lactil de uma forma alternada, recorrendo a uma 
di-esterificação, usando um ácido di-carboxílico nas posições O-6 alternadas. 
As amostras obtidas por estas duas vias foram submetidas a uma hidrólise 
enzimática. As enzimas utilizadas foram a lisozima e mutanolizina. As amostras digeridas 
foram ainda avaliadas em relação à afinidade para a enzima mCherry-PGRP-SA. Os 
produtos obtidos foram avaliados quanto à sua quantidade relativa de NAG e NAM, por 
uma cromatografia de troca iónica. 
Os resultados obtidos demonstraram que a via “molecular clamp” é a estratégia mais 
promissora permitindo a conversão de quitosano em unidade de NAG-NAM (1:1,18) numa 
composição semelhante à do PGN natural extraído de S. aureus. 
 
Palavras-chave: Peptidoglicano, quitosano, NAG-NAM, quimioenzimática, molecular clamp, 
lizosima, mCherry-PGRP-SA.  
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Abstract 
 
The bacterial peptidoglycan (PGN) has been directly associated with bacterial 
infections and antibiotic resistance. This work deals with the scientific community problem of 
obtaining peptidoglycan in a pure and reliable amounts for biological studies. The synthesis of 
PGN fragments. The synthesis of PGN fragments involves multi-step approaches and the 
isolation and purification from natural sources is usually difficult. 
 This work consisted on the investigation of a strategy that allows conversion of a 
food industry disposal, chitosan, in the valuable murein, a polymer of alternated NAG-NAM 
units that are cross-linked via short peptide bridges. Thus a chemoenzymatic approach was 
explored.  
In a first strategy a regioselective O-6-hydroxyl group protection was performed using 
two different groups, TBDPS and TPS, with subsequent introduction of the lactyl moiety at O-
3 position relying on the steric hindrance of the groups at O-6.   
On a second approach, a molecular clamp strategy was applied to block the access 
to some of the O-3 positions in alternate units. This approach involved a di-esterification at 
the -O6 positions of two alternate units, using a di-carboxylic acid, resulting in an alternated 
lactyl insertion in the following step. 
After the completion of the chemical modification of chitosan, the samples obtained 
were digested with two lytic enzymes, Lysozyme and Mutanolyzin. The digested samples 
were evaluated against its binding to the enzyme mCherry-PGRP-SA. Moreover the content 
in NAG:NAM of the samples produced was quantified by ionic chromatography.   
to the results obtained in this study revealed that the molecular clamp strategy is a 
promising route to convert chitosan into NAG-NAM oligosaccharides in a composition, 
NAG:NAM ratio (1:1.18) similar to the PGN isolated from S. aureus. 
 
Key words: peptidoglycan, chitosan, NAG-NAM, chemoenzymatic, molecular clamp, 
lysozyme, mCherry-PGRP-SA 
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 1 
1 Introduction  
 
1.1 Bacterial Infections 
There is a huge biodiversity of bacteria, in fact bacteria are the most abundant of all 
organism with an approximate population of 5x1030 individuals. These bacteria have a large 
number of shapes and sizes and can be found everywhere even if in radioactive waste or at 
the Mariana Trench.1 
 Although the majority of bacteria are harmless, there are a few, called pathogenic 
bacteria that are responsible for the bacterial infections. In matter of fact the two most 
deadliest diseases caused by bacterial infections are tuberculosis, caused by the 
Mycobacterium tuberculosis, which kills almost two million people every year and pneumonia, 
caused by Streptococcus pneumoniae, Gram-positive, and Pseudomonas aeruginosa, Gram-
negative bacteria, killing almost four million people every year.   
 The innate immune system is the first line of host defence against infection by 
pathogens. Infection by pathogenic microbes trigger several host-pathogen complex 
interactions that are mediated by pattern recognition receptors (PRR) that are highly 
conserved in evolution. Thus, during the early stages of infections, the innate immune 
responses play crucial roles in host defense and exert an intense influence on the resulting 
generation of adaptative immune responses. The understanding of the PRR that mediate the 
innate responses and their subsequent effect after receptor ligation will open room for the 
discovery and/or improvement of vaccines.2 
 In order to understand these immunologic responses, insects are the most usual 
model organism used in these investigations, since there are many mechanisms and 
pathways of their immune system that have been conversed during the species evolution. 
Drosophila melanogaster, or commonly fruit fly is one particular insect used in these kind of 
studies, since its genome was sequenced in the year of 2000, and Drosophila melanogaster 
has a high rate of reproduction, leading to the emergence of new generations in a short 
period of time.3 
1.2 Drosophila melanogaster innate immune response  
Although the Drosophila melanogaster genome sequence has been fully discovered its 
innate immune response to a bacterial infection is still under investigation..4 Figure 1.1 shows 
the actually accepted model of innate immune response of Drosophila melanogaster the two 
pathways of innate immune response are highlighted, the Toll and Imd pathways, which are 
responsible for inducing an antimicrobial peptide production response.  
Drosophila flies recognize the presence of peptidoglycan (PGN) with the help of 
specific PGN receptors: PGRPs (PGN recognition proteins). Depending on the composition of 
the injected PGN and the PGRP receptor involved, one of the two distinct signaling pathways 
is activated to produce antimicrobial peptides capable of killing the infected pathogen. 
 2 
In drosophila, the Toll pathway is required for resistance to Gram-positive bacteria, 
containing a lysine-type PGN, as well as fungi and yeast pathogens. The Toll receptor is 
activated when bacterial lysine-type PGN is recognized by PGRPs, specifically PGRP-SA and 
PGRP-SD, as well as Gram-negative binding proteins (GNBPs).5 These proteolytic cascades, 
which are not yet well characterized, lead to activation of Spätzle-processing enzyme (SPE) 
that leads to the Spätzle cleavage in the hemolymph. The processed Spätzle binds as a 
dimer to Toll leading to its dimerization in the plasma membrane leading to activation of three 
proteins MYD88, Tube and Pell and recruiting to the Toll receptor in the cytoplasmatic region. 
Subsequently, Cactus is phosphorylated and degraded by proteasome. Transcription factors 
Dif and Dorsal are released and moved through the nucleus and then activate the 
transcription genes that encode several antimicrobial peptides leading to the immune 
response.6  
Figure 1.1 Drosophila melanogaster model of Toll and Imd pathway activation, adapted from 
Lemaitre  et al (5) 
 3 
The Imd pathway is directly associated to activation by Gram-negative bacteria, 
possessing diaminopimelic acid-type PGN (DAP-PGN). The Imd pathway is activated by 
recognition of monomeric DAP-PGN by PGRP-LC/LE, then Imd interacts with dFADD which 
binds the apical caspase Dredd, enhancing the cell death activity and proteolytic processing 
the Dredd.7 At the same time a cascade is activated leading to the phosphorylation of IKK 
signaling complex which also phospholyrate the Relish. This leads to its cleavage and the Rel 
domain translocate to the nucleus, where it activates the transcription genes that encode 
several antimicrobial peptides leading to the immune response.7-9 
 Despite all the studies developed to understand innate immune response and the 
recognition process between host and bacteria during bacterial infection, some questions 
remain unanswered. How host receptors can recognize high molecular weight fragments of 
PGN at the surface of bacteria remains unsolved. Until today it is not clear which are 
thestructural requirements for PGN recognition by PGRPs. 
1.3 Bacterial Cell-Wall  
 Bacteria can be divided in two major groups the Gram-positive, with lysine-type 
PGN, and the Gram-negative, possessing a DAP-PGN, as it is shown in Figure 1.2. Gram-
positive bacteria cell wall has in its composition, PGN also called murein, teichoic acids (TA) 
and a cytoplasmatic lipid membrane. Gram-negative bacteria cell wall has in its composition 
cytoplasmatic membrane, DAP-PGN, also an outer lipopolysaccharide membrane, porins and 
lipoproteins. 
Figure 1.2: Representation of PGN; (a) Gram-positive; (b) Gram-negative; adapted from Royet et 
al (71b) 
I.1 I.2 
 4 
 These different components in their cell wall provides different characteristics and 
properties to these two groups of bacteria, properties such as thickness and permeability of 
the cell-wall, leading to a higher permeability in the Gram-negative bacteria and higher 
thickness in the Gram-negative ones, Figure 1.3.  
PGN is the major component of the bacteria cell wall, is normally composed by a 
disaccharide, monomer, of N-acetyl glucosamine (NAG) and N-acetyl muramic acid (NAM) 
and a tetra-peptide, L-Ala, D-iso-Gln, L-Lys, D-Ala, in the Gram-positive bacteria and L-Ala, D-
iso-Glu, m-DAP, D-Ala, in the Gram-negative bacteria. However, several modifications in both 
the glycan structure, and the aminoacids in the cross-linking bridge and the peptide stem, 
have been reported leading to numerous new structures of PGN. These modifications can be 
as varied as a glycine in the first position, a D-iso-glutamate in the second position or a D-
serine in the fifth position.10  The most common modification of the glycan strands include N-
deacetylation and O-acetylation at the NAM residue, these modification can occur with 
different ratios and degree of modification.11 
It has been shown that PGRP-SA is capable of recognizing small PGN fragments, 
isolated and purified from the cell wall of two Gram-positive pathogens Staphylococcus 
aureus and Streptococcus pneumonia.12 The follow-up of this research line13 has been 
hampered by limited availability of high-molecular weight PGN fragments in pure form from 
natural sources. 
In order to overcome this limitation S. Filipe group has been creating and analyzing 
S. aureus and S. pneumoniae mutants that produce PGN with different levels of 
polymerization degree at their bacterial surface. The group has also been studying how these 
bacteria may hide PGN from external recognition.14  
Thus, a critical limitation for further PGN investigation, is the limited availability of 
PGN in pure form from natural sources, and the need of ligand purification in reliable 
Figure 1.3 Bacterial cell wall representation; (a) Gram-positive bacteria cell wall; (b) Gram-
negative bacteria cell wall adapted from  
http://medimoon.com/wp-content/uploads/2013/04/gramstructure.jpg 
(a) (b) 
 5 
amounts. Indeed, the extraction and purification process of PGN presents several difficulties, 
due to the presence of TA and proteins that can contaminate the PGN fragments.15 16, 17 
 
1.3.1 Synthetic approaches to PGN  
 
The vast majority of glycoconjugates possessing NAG residues are linked via a 1,2-trans 
linkage. Glycosylation of the 4-hydroxyl group of NAG derivatives is notoriously difficult, due 
to the well-known lack of reactivity of this hydroxyl group which is due to a combination of 
steric hindrance and to the involvement of the N-acetyl group in a hydrogen-bonded 
network.18 The glycosylation of complex aglycones with glycosyl donors bearing a 2-
acetamido-2-deoxy functionality is usually unfeasible, due to the formation of a rather stable 
1,2-O,N-oxazoline intermediate during glycosidation (Figure 1.5-A), which significantly 
decreases the rate of glycosylation and yields. One strategy to avoid the formation of this 
stable intermediate consists on the use of disubstituted donors (Figure 1.5-B), by blocking the 
amino group. 
 
(a) 
(b) 
Figure 1.5: Schematic representation of glycosylation reaction; (a) via NAG donor; (b) via 
N-disubstituted donors  
 
Figure 1.4 Schematic NAG-NAM retro-synthesis approaches 
I.3 
I.4 
I.5 
I.6 
I.7 I.8 
I.9 
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Due to the high biological significance of bacterial PGN, some ingenious synthetic 
approaches have been developed (Figure 1.4). Special efforts have been dedicated to 
efficient synthetic approaches of glucosamine oligosaccharides. Indeed excellent synthetic 
strategies for general PGN fragments have been reported. 15-17 
Due to the difficulty in using NAG units, mentioned above, and n order to control the 
regioselectivity and enantioselectivity of the glycosylation step, the majority of these synthetic 
sequences developed so far involve a huge number of steps, as in Mobasherv’s approach, 37 
steps, with many protection and deprotection steps.17 Traditionally, as Fukase reported in the 
first synthesis of more than threesaccharide units, the amino group is protected with a 
temporarily protecting group (trichloroethoxycarbonyl – Troc, allyloxycarbonyl – alloc, 
trichloroacetyl – TCA and many others) which is replaced by acetyl group in a final stage of 
the synthesis, as it will be further explain.19  
On the other hand, Walker approach, uses as amino protecting group, TCP – 
trichlorophthalimide, instead of Troc. These two strategies seemed similar, once it depends 
on a donor and acceptor synthesis and then combine those two units through a new 
glycosidic bond. 
Moreover, despite the long multi-step sequences, these approaches involve many 
laborious work-ups/purifications/separations and costly reagents.  
Preliminary results revealed that the PGN minimal structure required to activate the 
Drosophila Toll pathway is a dimeric muropeptide, not yet synthesised, and that the free 
reducing end of the N-acetyl muramic acid residue is needed for activity.12 
Although some excellent strategies for general PGNs synthesis have been reported 
in the literature, one of the major difficulties associated with this particular PGN synthesis is 
the attachment of a disaccharide unit into a peptide chain linked to a solid support, and the 
cross-link peptide bridge assembly in such a macromolecule. 
 In a retrosynthetic overview, it can be divided in three fragments, a disaccharide 
NAG-NAM and two peptide chains, one that is directly bind to the NAM unit and the order that 
cross-link with other peptide chain as can be seen in Figure 1.6. 
In our group, we have already synthetized a NAG-NAM disaccharide has already 
been synthesized with a pentapeptide attached D-Ala-L-Lys-D-Gln-L-Ala-L-Ala. The first 
Figure 1.6 Retrosynthetic view of a dimeric PGN 
I.10 
I.11 
I.12 
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attempts were performed by preparing the NAG-NAM unit adapting the Fukase’s approach 
where the key step consisted on a stereoselective β-(1,4) glycosylationThe peptide was 
synthetized through Fmoc SPS (solid phase synthesis) with a global yield of 70%.20 
 As we can see in Figure 1.7, were used a 3:1 ratio (disaccharide:peptide) were used 
in the first step with a common coupling protocol, then the Div group of lysine was removed 
an then coupled with a five glycines group, with the same coupling protocol. The final step 
was the cleavage of the resin with 1% TFA/DCM, giving the glycopeptide with a yield of 3%. 
Additionally we have developed the solid-phase synthesis of a glycopeptide, and monitoring 
by high resolution magic angle spinning NMR. 21 
Recently the group have developed an efficient regioselective one-pot synthesis of 
Figure 1.7 Schematic NAG-NAM coupling to the peptide D-Ala-L-Lys-D-Gln-L-Ala, then coupled 
with five glycines and finally cleavageof the resin 
I.12 I.13 
I.14 I.15 
i) a) PhCHO, ZnCl2, 3 Å MS, RT, overnight; b) Ac2O, Pyridine, RT, overnight; ii) Morpholine, EtOAc, 
RT, overnight; iii) CCl3CN, CS2CO3, DCM, RT, 2h. 
i) BnOH, AcCl, 80oC, 3h; ii) PhCHO, ZnCl2, overnight; iii) Ethyl L-(S)-2- trifluoromethanesulphonyloxy- 
propionate, NaH, DCM, RT, 3h; iv) Pd(PPh3)4, AcOH, TrocCl, RT; v) BH3Me2N, BF3OEt2, RT, 3h. 
A 
B 
Figure 1.8: Synthesis of glucosamine Donor (A) and Acceptor (B) 
I.16 I.17 I.18 I.19 
I.20 I.21 I.22 I.23 
I.24 I.25 
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glucosamine building blocks22 (Figure 1.8 and Figure 1.9). A properly N-protected 
glucosamine fully silylated at O-3, O-4 and O-6, was the key intermediate to achieve 
glucosamine building blocks, with a different substitution pattern, via a one-pot sequential 
procedure.  
A one-pot strategy seems to be the most attractive way to achieve NAG-NAM 
disaccharides in opposition to the several synthetic strategies developed for the synthesis of 
carbohydrates and especially for the construction of complex oligosaccharides,23 Figure 1.9. 
Such an approach allows the protection of the hydroxyl groups with suitable groups 
while avoiding multi-step sequences, difficult and challenging purification methods and it 
provides control for a regioselective glycosylation.19, 20, 22 
Recently, the group has also reported the synthesis of a versatile intermediate 
towards NAM-NAG disaccharide, using a strategy that involves a multi-step approach with 
many purification steps.24 Despite the novelty of the approach and the key intermediate 
formed, the overall yield of the NAM-NAG moiety was only 2% in 11 steps. Due to the lack of 
resources, lack of pure and homogensous PGN, and an extremely hard-core synthesis 
providing PGN fragments with extremely low yields, our goal consists on finding the right 
strategy towards PGN synthesis. The use of a renewable starting material, such as a natural 
polymer would open a completely new and sustainable route to achieve PGN fragments of 
controlled degree of polymerization and high purity.  
Chitin is a polymer that shares the same basic carbohydrate backbone as that of 
PGN. The advantage of the abundance and structure of chitin, a biopolymer having immense 
potential for chemical modification and for structural possibilities.  
Figure 1.9 Synthesis of disaccharide NAG-NAM 
i) TMSOTf, DCM, 3A MS, -15 oC; ii) Zn-Cu, THF: AcOH: Ac2O (1:1:1), then Ac2O/pyridine; iii) LiOH, THF:1,4-
dioxane:H2O; iv) Pd(OH)2, H2, AcOH, RT.  
I.19 I.25 I.26 
I.27 
I.28 
I.29 
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1.4 Chitin and Chitosan 
Chitin is the second most abundant polysaccharide after cellulose, can be obtain by 
extraction from crustaceans shells and can also be found in the cell wall of some fungi and 
algae. Chitin is constituted by of β-1-4-N-acetylglucosamine (GlcNAc) and D-glucosamine 
(GlcN) units, Figure 1.10.24-26 Chitosan is the copolymer, linear heteropolysaccharide, product 
of chitin’s deacetylation reaction27, with a DA (degree of acetylation) <50%, while chitin has 
DA=100%. Being a natural biopolymer, chitin has proprieties as non-toxic, biocompatible, 
biodegradable and has been explored in many distinct areas such, anti-bacterial agent28, fat-
binding agent29, cell protection from carcinogenesis30, hypocholesterolemic agent31 , 
antioxidant 32, matrix for drug release33 artificial skin34 and wound dressing material35. Chitin 
has three different conformations α-, β- and ϒ-chitin that dependent on the animal source.36	  	  	  
Due to its poor solubility many strategies have been developed in order to obtain 
derivatives by chemical modification, with the objective of maximize their properties in the 
application field but this problem still the major setbackin the use of chitin and chitosan.37, 38 
Depending on the source and consequently the conformation of the chitin, different solubilities 
are associated. α-Chitin has more intramolecular forces, hydrogen-bonds associated, than β-
chitin that is more used due to this fact.38 Chitin showed to be soluble in water but its DA must 
be in a range between 45-55%.39 Several solvents have proved to dissolve chitin and 
chitosan, depending on its natural source has a different solubility, as shown in table 1.40 
1 
2 
Figure 1.11- Antiparallel chain arrangment in α-chitin.(1); parallel arrangement in β-chitin. 
adapted from colocar aqui autores reference 33(e) (2) ou colocar A e B 
O
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O
HO NHR
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O
HO
NHR
OH n
Figure 1.10 Molecular skeleton of chitin (R=acetyl) and chitosan (R=H>50%) 
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Tabela 1-1: List of solvents and ionic liquids used to dissolve chitin and chitosan 
Chitin Chitosan 
N,N-dimethylacetamide, 5-10%(wt) LiCl, 
Diluted acids 
(phosphoric, sulfuric, citric, sebacic, acetic) 
N,N-dimethylacetamide, N-methyl-2-pyrrolidone, 
5-8%(wt) LiCl Dimethylsulfoxide 
Methanol saturated with calcium chloride 
dihydrate p-Toluene sulfonic acid 
1-allyl-3-methylimidazolium bromide 10-Camphrosulfonic acid 
1-butyl-3-methylimidazolium acetate 1-butyl-3-methylimidazolium chloride 
1-butyl-3-methylimidazolium chloride 1-butyl-3-methylimidazolium acetate 
hexafluoroacetone or hexofluoro-2-propanol 1-allyl-3-methylimidazolium acetate 
 
In order to follow the degree of deacetylation or the depolymerization progress, and 
accomplish the characterization of the chitoligomers many technics have been used to 
provide this information, such as MALDI-TOF, 1H-NMR and chromatographic techniques as 
GPC.41-43 The degree of deacetylation can be calculated directly from the observation of the 
peak’s intensity on the 1H-NMR spectra as shown in equation 1. 
𝐷!"#$    % = 1 −
!
!!!"!
!
!! !!!!!
×  100  (1) 
While the applications of chitin and chitosan in a wide range of areas, have been 
reviewed by several authors, the regiosselective and chemoselective modification of these 
polymers has been scarcely reported. 26, 44  
Thelow molecular weight chitosan has greater potential for application in many 
different areas, due to the higher solubility.. In order to obtain low molecular weight chitosan, 
many strategies of hydrolysis have been explored. This depolymerization reaction can occur 
by chemical hydrolysis, by the use of a strong protic acid such as nitric acid45, diluted sulfuric 
acid46 and hydrochloric acid43, 47, 48, which is the most common way of hydrolysis of chitosan, 
or via enzymatic hydrolysis.49 Aditionally the physical mechanism of depolymerization via the 
ultrasonic depolymerization42, 50, which is directly affected by the geometry of the glass-wear 
used, has also been reported42. Apart from that there are also alternative methods, such as γ-
irradiation depolymerization29 and depolymerization assisted by microwave51.  
1.4.1 Chemical modification of chitin and chitosan 
Chitosan and chitin have distinct functional groups with different reactivities: O-6 - a 
primary hydroxyl group; O-3 - a secondary hydroxyl group; and the amine group(figure 1.6). 
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During the last few years, some developments on the chemoselective and regioselective 
modification of chitosan have been reported. 
1.4.1.1 N-modifications 
The protection of the amine group in chitosan is fundamental in order to achieve different 
physical properties with consequently easier handling and to achieve different applications. Thus 
several methods were developed, such the phtaloylation, acylation or carboxyacylation and 
quaternization. These methods and the chemical methodology used will be discussed in the following 
sections. 
1.4.1.1.1 N-Phthaloylation 
One method to prepare the N-phthaloyl chitosan consists on using aqueous acetic 
acid reaction media. Changes in the concentrations of aqueous AcOH to 10.0% maximum did 
not affect the regularity of the products, Figure 1.12. It should be emphasized that the 
irregular structure of the chitosan intermediate and acidic conditions caused by partial 
hydrolysis of phthalic anhydride allowed a homogeneous reaction in pure water. Since the N-
phthaloylation of chitosan is one of the most important reactions for the design of advanced 
materials, a reaction that requires no organic solvents will great contribute to the 
advancement of green chemistry.52	 
Figure 1.12 Scheme of amine moiety protection with phthalic anhydride 
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 Other method consists on reacting fully deacetylated chitosan with phtalic anhydride 
in DMF with 5% of a co-solvent, such as ethanol, water, ethylene glycol and methyl 
cellosolve. Treatment of chitosan with phthalic anhydride, generally results in partial O-
phthaloylation in addition to the N-phtaloylation. However in the present of 5% water, as co-
solvent the partial O-6 phtaloylation are removed byhydrolysis, resulting in a 1.0 degree of N-
substitution in chitosan, Figure 1.13.53 
1.4.1.1.2 N-carboxylacylation 
N-carboxymethylchitosan is the most typical amphiprotic chitosan with amine and 
carboxylic acid groups in the molecule. It is a unique macromolecular structure that provides 
Figure 1.13 Schematic water-influence in the solvent composition on the chitosan and 
phthalic anhydride, reaction product 
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Figure 1.14 Synhesis of a regioselective amphiprotic chitosan; (a)N-phtaloylation; (b) position 6 
bromination; (c) position 6 azidation; (d) Husigen cycloadition; (e) phtaloyl group removal 
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specific properties and applications. However, preparing regioselective amphiprotic chitosan 
can be difficult by N- and O-carboxymethyl esterification using monochloroacetic acid. This 
derivative can be prepared via copper-catalyzed Huisgen cycloaddition, as it is shown further 
on Figure 1.14.54 
N-carboxymethyl chitosan is obtained by using glyoxylic acid: the product is a glucan 
carrying pendant glycine groups. The solubility of chitosan in aqueous solutions of lithium and 
magnesium halides varies in the following order: LiCl < LiBr < LiI; MgCl2 < MgBr2 < MgI2. A 
method for selective production of mono-N-(2-carboxyethyl)chitosan (NCE-chitosan) was 
developed via synthesis in gel (concentration of chitosan 4–20%) of the magnesium halides 
solution (1.1–3.5 M) using acrylic acid. The use of MgI2 or MgBr2 in the reaction, provides 
relative greater amount of the monosubstituted amino groups (73–87%) in comparison with 
their absence. It is known that the bioactivity of carboxymethyl chitosan vary according to the 
ratio mono-:disusbtitution- of the amino groups.55 
	  
Water-soluble N-(4-carboxybutyroyl), Figure 1.15, chitosan derivatives with different 
degrees of substitution (DS) were synthesized to study the antimicrobial activity of chitosan. 
Chitosan in a solution of 2% aqueous acetic acid–methanol was reacted with different 
amounts of glutaric anhydride to give N-(4-carboxybutyroyl) chitosans at different DS. The 
chemical structures and DS were characterized NMR spectroscopy, which showed that 
acylation took place at the amine group. This synthesis gives a new chitosan derivative, 
soluble in water-, diluted acid or diluted base. The antimicrobial activity was investigated 
against the most economic plant pathogenic bacteria of Agrobacterium tumefaciens and 
Erwinia carotovora and fungi of Botrytis cinerea, Pythium debaryanum and Rhizoctonia 
solani. The antimicrobial activity of N-(4-carboxybutyroyl) chitosans revealed to be more 
efficient than the native chitosan with the increase of the DS. A compound of DS 0.53 was the 
most active one with minimum inhibitory concentration (MIC) of 725 and 800 mg/L against E. 
carotovora and A. tumefaciens, respectively and also in mycelial growth inhibiation against B. 
cinerea (EC50 = 899 mg/L), P. debaryanum (EC50 = 467 mg/L) and R. solani (EC50 = 1413 
mg/L).56 
A different approach to carboxyalkylation of chitosan consist on gel state approach by 
using aza-Michael addition and substitution reactions. Various reagents were applied 
including acrylic and crotonic acids, and halocarboxylic acids. The reaction of chitosan with 
Figure 1.15 Synthetic scheme of N-(4-carboxybutyroyl) chitosan derivatives using different mol 
ratios of glutaric anhydride	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halocarboxylic acids showed no target product formation, either in solution or in the gel state. 
In the case of acrylic, crotonic, halocarboxylic acids, the reaction performed in the gel state 
(concentration of chitosan 20–40%) showed higher degree of substitution at lower reaction 
time and temperature than in diluted solutions (concentration of chitosan 0.5–2%). This 
method provided higher yield of the product per reaction volume, lower reaction time and 
temperature, lower consumption of solvents and reagents, and no need for stirring of the 
reaction mixture. All of these factors make the gel technique advantageous for large-scale 
production and turn the synthesis of these compounds more environmental friendly.57 
 
O-Methyl free N,N,N-trimethyl chitosan (TMC) can be synthesized by treating 
chitosan with formic acid and formaldehyde, followed by methylation with CH3I. Then TMC is 
carboxymethylated by monochloroacetic acid to obtain N,N,N-trimethyl-O-carboxymethyl 
chitosan (TMCMC), Figure 1.16. Their antibacterial activity was investigated against 
Staphylococcus aureus and Escherichia coli. It seems to be a decreasing of the antibacterial 
activity of TMC as the degree of substitution increased at pH 5.5, however the structure 
activity relationship was the opposite at pH 7.2. TMCMC seems to have less activity than 
TMC, and also its activity decreased as the degree of carboxymethylation increased. The 
experimental results showed that the antibacterial activity of N,N,N-trimethyl amino group was 
lower than other non-quaternized amino groups, and carboxymethylation did not enhance the 
antibacterial activity directly.58	 
1.4.1.1.3 Quaternization 
N,N,N-Trimethyl O-(2-hydroxy-3-trimethylammonium propyl) chitosans (TMHTMAPC) 
with different degrees of O-substitution can be prepared by reacting O-methyl-free N,N,N-
trimethyl chitosan (TMC) with 3-chloro-2-hydroxy-propyl trimethyl ammonium chloride 
(CHPTMAC). The products were investigated for antibacterial activity against Staphylococcus 
aureus and Escherichia coli at pH 5.5 and pH 7.2 conditions. TMHTMAPC exhibited 
enhanced antibacterial activity compared with TMC, and the activity of TMHTMAPC 
Figure 1.16 Synthesis of N,N,N-trimethyl O-carboxymethyl chitosan 
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increased as well as the DS increased. The use of divalent cations showed to be related to 
the lost of antibacterial activity of O-carboxymethyl chitosan and N,N,N-trimethyl-O-
carboxymethyl chitosan. However it did not occur with such intensity in the repression on the 
antibacterial activity of TMC and TMHTMAPC. This indicated that the free amino group on 
chitosan backbone is the main functional group interacting with divalent cations.59	  	  
The antioxidant properties of quaternized chitosan conjugated with gallic acid or 
caffeic acid were tested against hydroxyl-radical, superoxide-radical and DPPH-radical were 
evaluated in vitro, respectively. The scavenging activities of the obtained gallic acid-
quaternized chitosan and caffeic acid-quaternized chitosan seemed to be a remarkable 
improvement over those of either chitosan or quaternized chitosan. Moreover, the scavenging 
effect indices of the products were all higher than 90% at a concentration of 1 mg/mL. Since 
gallic acid-quaternized chitosan and caffeic acid-quaternized chitosan are easily prepared 
and possess improved potential activities, these materials may represent an attractive new 
platform for another utilization of chitosan.60	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1.4.1.2 O-modification 
Various protecting groups have been used for the protection of chitin’s and chitosan’s 
hydroxyl groups, in an attempt to modify chitosan derivatives properties, such as solubility, 
and to enable N-selective modifications. The most commonly used hydroxyl protecting groups 
are: acetyl, tosyl, trityl and silyl groups, such as trimethylsilyl (TMS) or tert-butyldimethylsilyl 
(TBDMS), Figure 1.17.61, 62 
Usually O-modification at the O-6 position is commonly performed by the 
regioselective protection of the amine group with phthaloyl group.  
The primary hydroxyl group in position 6 is very versatile, since is more reactive than 
the secondary hydroxyl in the position 3, enabling a wide variety of transformations. It can be 
regioselectively protected or transformed into different functionalities, such as a halide, an 
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azide or an amine group.  
Usually the O-6 position is selectively protected with bulky groups such as the 
triphenylmethyl group or the silyl groups, leaving the position O-3 capable of future 
modification. In these procedures the N-phthaloyl protected derivative is frequently used, 
increasesing the solubility in organic solvents and thereby enabling the introduction of the 
proper group at the primary alcohol. At the end, the phthaloyl group can be easily cleaved by 
treatment with hydrazine.  
The advantage of O-6-protected polymers, is the protection of the more reactive, 
primary hydroxyl, group leads to an increase of polymer solubility in organic solvents. 
Trityl group is also placed in the polymer to increase the solubility in organic solvents. 
It is usually introduced reacting the N-protected chitin or chitosan with trityl chloride in 
pyridine.  
Tosyl group is also very used as protecting group of O-6 position, since it has a good 
leaving character making tosylated polymer a very useful intermediate for further reactions at 
position O-6. Several nucleophiles such as sodium iodide, sodium borohydride, and 
potassium thioacetate63 were used to substitute the tosyl group to yield iodo-, deoxy-, and 
acetylthio- chitin derivatives, respectively, Figure 1.18.  
The preparation of tosylated derivative could be achieved by reaction of chitin with 
tosyl chloride (p-toluenesulfonyl chloride) in a DMAc/LiCl solvent system.63-65 
Once functionalized, the resultant tosylated and fully N-acetylated chitin can react 
with the sodium salts of ethyl p-hydroxybenzoate, diethyl malonate, and diethyl phosphite, in 
DMAc, to afford the corresponding chitin derivatives of O-6-ethyl benzoate-chitin, 6-deoxy-
diethyl malonate-chitin, and 6-(deoxydiethyl) phosphitechitin, respectively, Figure 1.19.64, 66  
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O-6 modification of N-protected chitosan is a strategy commonly employed to modify 
chitosan and create an amphiprotic polymer. These modifications offer several advantages, 
since the resulting polymer possesses tunable solubility and a nanosized structure which 
enable several applications such as drug delivery systems. Usually, this amphiprotic 
character can be achieved by placing a suitable group in position O-6 such as a carboxylic 
acid, which can makes the polymer soluble under basic or acidic conditions. In neutral 
aqueous solution, a click chemistry approach has been developed, producing polymer 
nanoparticles, leading to the synthesis of a regioselective amphiprotic chitosan derivative.  
The hydroxyl group can be converted to the brominated derivative that in turn is 
transformed in the azide derivative. The azide moiety at the C-6 position is then successfully 
converted to a 1,4-triazole linker with an appropriate R group, by a Huisgen cycloaddition 
between 6-azido-6-deoxy-N-pthaloyl-chitosan and an adequate propiolate in the presence of 
Cu(I) catalyst.54, 67   
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The same group also verified that the chitin type (α or β) has a high influence on 
some chemical modifications. After an exhaustive study of reaction conditions, the authors 
verified that functionalization of hydroxyl groups of squid β-chitin with trityl or benzyl groups 
proceeded much more easily than those of shrimp α-chitin. While in α−chitin, the O-6-trityl 
derivative is prepared by reaction of trimethylsilylated chitin, the β-chitin was found to exhibit 
higher reactivity and direct tritylation of β-chitin was achieved in a quantitative way, Figure 
1.21.  
3,6-O-Dibenzylation of β-chitin was also accomplished in simple one-step reaction, to 
afford the corresponding protected derivatives that exhibited good affinity for organic 
solvents.68  
For the regioselective protection of chitin, Figure 1.21, the benzyl group was also 
explored as an efficient protecting group for O-3 postion, in combination with other protective 
groups including triphenylmethyl (trityl) for O-6 and acetyl or phthaloyl for N-2. Chitin was first 
silylated to form 3,6-O-trimethylsilyl derivative that was further reacted with trityl chloride to 
afford 6-O-trityl-chitin.  This derivative was benzylated to give 3-O-benzyl-6-O-trityl-chitin, in 
which the trityl, benzyl, and acetyl groups could be selectively removed to afford three 
different derivatives with a free reactive hydroxyl of amine group at O-6, O-3, or N-2, 
respectively.60 
Azide moiety in position 6 can also be transformed in an amine group via formation of 
a triphenylphosphinimine intermediate that is hydrolyzed using aqueous hydrazine, which 
also led to the removal of the N-phthaloyl group. This sequence gave 6-amino-6-deoxy-
chitosan, which, unlike chitosan, is soluble in water at neutral pH, Figure 1.22.69 
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Conversion of the O-6 primary hydroxyls to carboxylate groups could be achieved using 
TEMPO/NaBr/NaClO oxidation systems making the water-insoluble a-chitin become water-
soluble. 70 
Chitosan is highly versatile biopolymer and can be easily converted in a wide range 
of functional groups, due to be possibility of chemoselective modification of its functional 
groups. Biological studies with PGN are limited by the difficulty in obtaining the pure, 
homogeneous and high molecular weight fragments of PGN. Adding these two facts we 
though “Is it possible to we convert chitosan into PGN’s sugar backbone?” and it is in this 
context that the present work was developed. We aimed to contribute to a sustainable and 
efficient route that enables the conversion of available chitin/chitosan into valuable PGN 
fragments. 
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2 Results and Discussion 
Since biological studies to investigate how the host receptors can recognize high 
molecular weight fragments of PGN at the surface of bacteria are limited by the amount and 
purity of natural PGN, we embraced the challenge of preparing pure and homogenous PGN 
fragments in order to overcome the major setback in this research field.  
 To achieve this goal, we envisaged that a biopolymer, that shares the same basic 
carbohydrate skeleton as PGN, could be used as starting material towards PGN. The aim 
consisted on combining chemical and enzymatic methods to modify the polymer  in order to 
convert it into NAG-NAM units.  
Chitin is a β-1,4-linked NAG biopolymer thus, to convert chitin into PGN, a lactyl unit 
must be introduced in alternating NAG units to which peptides may be connected. The main 
advantage of this proposal is the fact that chitin/chitosan already have the challenging β-1,4 
glycosidic bond installed between NAG/glucosamine units and many orthogonal 
protection/deprotection strategies to achieve enantioselective glycosylation as well as the 
preparation of donors and acceptors will be avoided.  
Chitin is very abundant in the biomass of shellfish discarded every year, is 
commercially available with different degrees of polymerization. However chitin’s low solubility 
represents a limitation to the required chemical modification. On the other hand chitosan, the 
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alkaline derivative of chitin, has a better solubility profile and is amenable to chemical 
modifications.  
In an initial stage of the project we aimed at preparing small chitooligomers and 
perform its structural elucidation. The idea was to establish a methodology for obtaining 
chitooligomers of controlled molecular weight for further chemical modification towards PGN.  
In a second stage of the project the main aims were: 
- To perform chitin/chitosan regioselective chemical modification; 
- To establish a methodology to introduce the lactyl unit into alternating units of 
NAG in the modified chitin/chitosan; 
- To digest NAM-NAG polymers by lysozyme-like enzymes to release homogenous 
NAM-NAG polymers; 
- To characterize the fragments obtained using different spectroscopic and 
chromatographic techniques; 
According to the retrosynthetic analysis depicted in figure XX, two different strategies 
were explored to introduce the lactyl moiety in alternating protected glucosamine units. After 
removal of the protecting groups, the NAG-NAM content was evaluated by using enzymatic 
assays trough muramidases and lysozyme digestion. The amount of NAG-NAM units present 
in the final polymers, and thus the success of the approaches, was analyzed by HPLC-UV 
and HPLC-MS analyzes. Additionally PGRP affinity to the prepared samples was also 
evaluated by pull-down assays and by SDS-PAGE electrophoresis.  
This work and the results obtained will be presented and discussed in the present 
chapter that is organized as follows: 
• Preliminary studies; 
• Polymeric chitosan chemical modification; 
• Enzymatic studies of the final products 
2.1 Preliminary studies 
 
To date, X-ray crystallography of PGRPs has been performed with a NAM unit 
attached to a penta or a tripeptide stem, performed to achieve the structure of human 
PGRPs.71 Thus interaction studies of PGRPs with higher molecular fragments involving both 
NAM and NAG units have not been reported so far.  
In this context, the first approach to produce NAM-NAG polymers from chitosan consisted on 
the preparation of small chitooligomers of controllable DP that could be isolated, 
characterized for further functionalization. The main idea was to develop a protocol in order to 
obtain oligomers of small molecular weight that could be further transformed with a control 
over the polymer size.  
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2.1.1 Chitosan hydrolysis 
Several authors have already performed Chitosan hydrolysis, as mentioned in 
Section 1.4. Most of the reported procedures covering chemical and physical hydrolysis, have 
limited control over the DP of the fragments, involve harsh conditions, and/or are difficult to 
reproduce. For the current project a reproducible procedure with control over the DP would be 
desirable. Hence first experiments were carried aiming at exploring novel hydrolysis 
conditions as well as developing a protocol that allows control of the DP (solvent, reaction 
time, temperature, concentration) in order to obtain fragment of low molecular weight. Acidic 
medium was chosen for the hydrolysis experiments, and the mechanism of acid assisted 
hydrolysis of chitosan is depicted in Figure 2.3. An investigation of several hydrolysis 
methods and conditions was performed, as summarized in Table 2-1.  
 
Table 2-1 Summary of the hydrolysis’ work 
Concentração de 
quitosano 
Tempo 
(h) Condições Isolamento 
Resultados  
DA 
(%) DP 
Mn 
(Da) 
Mw 
 (Da) PDI 
10 mg/mL 
(5% ácido acético) 
 
6 Banho de ultrassons 
Centrifugação a 
5000 rpm e 
liofilização 
Nada aconteceu 4 
Sonda de 
ultrassons 
6 Sonda de ultrassons 
40 mg/mL 
(HCl 1M) 6 
Banho de 
ultrassons 
N. D. 20 mg/mL 
(HCl 12M) 0.5 - 1 72ºC 
Neutralização e 
evaporação do 
solvente 
20 mg/mL 
(HCl 12 M) 3 
Evaporação do 
solvente e diálise 12 2-18 729 1002 1.37 
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4 
Evaporação do 
solvente e 
precipitação com 
acetona 
 2-16    
20 mg/mL 
(HCl 12 M) 5 
Evaporação do 
solvente e diálise 11 2-15 674 860 1.28 
 
 
First methods explored consisted on the use of a physical, ultrasonic assisted 
hydrolysis using an ultrasound bath over 6 hours, 10 mg/mL of chitosan in diluted acetic acid 
(5%) (table 2.1, entry 1). This method would represent a milder approach compared to the 
harsh conditions reported using concentrated solutions of HCl.43, 47, 48 The results obtained 
demonstrated that this is not a good approach since the chitosan did not dissolve in the 
reaction media and little depolymerization was observed (table 2.1, entry 4).  A literature 
procedure was then adopted,42 in which an ultrasound probe was used, under the same 
previous conditions [10 mg/mL of chitosan in acetic acid (5%)]. Different reaction times were 
tested and after 4 hours, no depolymerization was observed. When the reaction time was 
extended to 6 hours, also no results were obtained (table 2.1, entry 2-3). Due to probe 
limitations, it was not possible to increase the acid concentration. Thus other conditions were 
next tested, using the ultrasound bath, and treating chitosan with a solution of of 1 M HCl, 40 
mg/mL of chitosan. The reactions were monitored by TLC and when HCl was used hydrolysis 
fragments were observed on the TLC plate corresponding to different chitooligomers obtained 
(Figure 2.4). 
Concerning the work-up/quench of the reaction, in the 
first experiments to the mixture was centrifugedand then the 
supernatant was lyophilized. It was expected that the soluble 
fractions of the oligomers would contain the oligomers of lower 
DP. However this was not observed at the TLC glimpse of 
hydrolysis. Next a new work-up procedure was employed.  
Furthermore a new reaction condition was tested (Table 
2.1, entry 8), consisting on the treatment of chitosan in a 2 % 
(w/v) concentration in HCl 12 M. The use of a strong acid would 
promote a more efficient hydrolysis improving the amount of 
chitooligomers produced. Once again the problem of work-up 
remained, and in order to avoid HCl evaporation, the acid was 
first neutralized with a solution of 10 M NaOH, which generated a 
huge amount of NaCl. This procedure hindered any sort of 
characterization. Next it was decided to proceed with the HCl 
evaporation as much as possible on a rotary evaporator, and use 
as less NaOH as possible to bring the pH value to 3. Next step 
consisted on the separation of the oligomers by dialysis. The pH 
value (3) was the minimum pH advisable to use with the dialysis 
membranes. The dialysis process was preformed to separate the hydrolysis product in two 
Figure 2.4 TLC of 5 hours 
dialysis. (G) – I.5; (I) - inside of 
dialysis membrane; (F) - 
outside of dialysis membrane. 
Eluent 70% H2O 20% 
isopropanol 10% aqueous 
ammonia, revelled with 10% 
sulphuric acid in ethanol 
ª The acetylation degree was calculated based on equation 1; b the n, Mn, Mw and DPI (Mw/Mn) were calculated 
trough MALDI-TOF analysis  
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fractions: outside the dialysis membrane oligomers with a maximum weight of 1500 Da; and 
inside the membrane oligomers ≥1500 Da.  
The fractions obtained (outside and inside of the dialysis membrane), were then 
analyzed by MALDI-TOF (Figure 2.5), TLC (Figure 2.4) and GPC. It was concluded that the 
oligomers isolated from the reaction performed with 5 hours hydrolysis, II.8, as shown in 1, 
Figure 2.4 and Figure 2.5, a distribution of chitooligomers with a Mn=674 and Mw=860 which 
led us to conclude that these conditions were ideal to obtain small DP chitooligomers. By 
direct analysis of Figure 2.5, one can observe: consecutive m/z=161 Da gaps that represent 
the glucosamine unit; m/z=524 Da represent a DP3+Na+ which was the ionization ion used in 
this experiment. In this acquisition window it is possible to identify chitooligomers from DP3 to 
DP12. However in the data sheet of the entire MALDI-TOF experiment it is possible to identify 
chitooligomers from DP2 to DP15. 
The GPC analysis was compromised by the lack of control samples to validate the 
results. The control samples consist of samples of small oligomers that are expensive but are 
currently being prepared in our lab. These controls will allow to perform the GPC analysis and 
establish the molecular weight of the oligomers prepared and validate the MALDI-TOF 
experiments carried. Nevertheless, for some samples analyzed the GPC analysis is in 
accordance with the mass spectrometry data.  
Concerning the hydrolysis yield, for the reaction carried with 5 hours, a two-time 
dialysis was performed (table 2.1, entry 8) and 1.85 g of oligomers were obtained outside of 
the dialysis membrane, leading to a yield of 92.5 %. As a preliminary result but we expected 
Figure 2.5 MALDI-TOF spectra from II.8 
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to obtain a fraction of oligomers lightly higher on Mn and Mw, and also narrow the DP if 
possible.  
The reaction was further tested with 3 and 4 hours of hydrolysis (table 2.1, entry 6, 7). 
The results obtained demonstrated a change in Mn and Mw as shown in table 2.1. The 
results obtained suggested that the DP range was not only dependent on the reaction time. it 
could be obtain by dialysis but it seems impossible   
2.1.2 N-modification of the oligomers produced 
 In order to separate the obtained mixture of oligomers of different DP into fractions of 
the same molecular weight, and further convert them in the sugar backbone of PGN, the next 
step consisted on the regioselective protection.  
 Several amine-protecting groups were then considered. The aim was to protect the 
amine with a group that not only protects the amine from reaction in an advanced stage of the 
synthesis but also prevents H bond donor activity of the amine moiety, increasing the 
solubility in organic solvents. Two protecting groups were chosen, phthalic anhydride and 1,2-
di-phenyl maleic anhydride, in order to evaluate the influence of the steric hindrance of a N-
protecting group in the lactyl insertion in a later stage. 
 Most reported procedures for chitosan N-phthaloylation62 are carried in DMF. Due to 
the problems of product isolation in DMF, dioxane and THF were considered as alternative 
solvents. However, this reaction requires high temperature and thus the solvent boiling point 
is crucial. Reactions were then carried with DMF containing 5% of water to prevent the O-6 
protection.53 
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After isolation, precipitation with a mixture of ice water and methanol 1:1, the products 
were characterized by MALDI-TOF and NMR. The MALDI-TOF analysis, Figure 2.7, 
confirmed the presence of oligomers with a DP5, however as the starting material had DP15 
and during the work-up process no loss of higher molecular weight N-phthaloyl chitosan 
occurred. It could indicate that the MALDI-TOF protocol used for sample preparation was not 
the most appropriated to analyze this sample. Since MALDI-TOF analysis requires a volatile 
solvent to apply the sample onto the matrix, automatically excluding DMF, the sample was 
dissolved in water.  As the oligomers of small DP ones were the most soluble in water, the 
higher DP oligomers might have been excluded from the analysis and that would justify the 
observed obtained chromatogram. 
To proceed with the use of these oligomers, a proper characterization is required, as 
well as pure samples of small oligomers to be used as control in GPC analysis. These facts 
led us to focus on the modification of polymeric chitosan, using the know-how of working with 
oligomers as preliminary studies to the chemical modification of polymeric chitosan. Thus to 
proceed with the established aims of preparing NAG-NAM polymers, the next step consisted 
in the use of the commercial chitosan directly in the chemical modification. 
The oligomers produced herein are currently being separated to obtain oligomers of 
defined DP. 
  
Figure 2.7 MALDI-TOF spectra from II.10 
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2.2 Polymeric chitosan chemical modification 
In our demand to convert chitosan into the PGN’s sugar backbone, two distinct 
strategies were designed to block alternated O-3 position: an approach in which all the O-6 
position are equally protected with the same group (the influence of the group steric 
hindrance was evaluated); and an approach in which a molecular clamp is used to create 
different accessibilities to O-3 (Figure 2.8). As the chitosan has the same basic scaffold as 
murein the challenge consisted on finding the right strategy to achieve discrimination between 
alternate O-3 positions to insert the lactyl group and achieve the muramic acid moiety. 
Acetylation of the amine moiety was performed in a later stage to recreate the NAG-NAM 
sequences.  
  
Figure 2.8 Synthesis plan of PGN sugar backbone or murein; (A) asymmetric protection route; (B) 
silylation route 
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2.2.1 O-6 Silylation route 
To establish the best route for chitosan modification towards the murein main 
scaffold, the first and most direct route consisted on the exploration of a purely statistical 
insertion of lactyl moiety. With this tough in mind a silylation route was first considered, which 
basically consisted on the silylation of all the O-6 positions, after an amine moiety protection 
with a proper group, as shown in section 2.1.2.  
As Figure 2.9 shows the strategy relied on amine moiety protection, (two different 
groups were considered), followed by regioselective O-6 silylation, with distinct groups 
varying on their bulkiness. After O-6 protection the insertion of the lactyl moiety at O-3 
position, was performed varying the equivalents of the corresponding reagent to evaluate the 
statistical distribution of that insertion, and finally a sequence of deprotection steps, starting 
with N-deprotection followed by N-acetylation and the O-6 silyl group removal. 
 Since the polymeric chitosan was used as starting material, the terminal O-4 
hydroxyl group was despised, as well as the reducing end, once the polymeric chitosan has a 
DP about 1800. This commercial chitosan was ready available and was amenable to 
manipulate. However the characterization of the products obtained revealed even more 
difficult than the previous oligosaccharides obtained from the hydrolysis (preliminary results). 
So the samples obtained in this route were characterized based on IR and NMR CP/MAS. 
The first protection steps have already been reported in the literature for similar structures, so 
these procedures were adopted for the N-protection and O-6-silylation.62 
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As in the previous preparation of chitooligosaccharides, the first step of the strategy 
was the N-protection with phthalic anhydride and 1,2-di-phenyl maleic anhydride (Figure 
2.11). The product isolation seems to be easier than the oligomers isolation, as expected, 
though a simple quench with ice water, generated a precipitate in a 72% and 80% yield, in the 
phthalic anhydride and 1,2-di-phenyl maleic anhydride respectively Despite the high yields 
obtained, the protection with DPM anhydride, of II.16, decreased the solubility of the 
protected chitosan derivative in every solvent, even DMF or DMSO. Thus it was decided to 
continue the synthesis plan with I.32. In fact we planned to use II.16 in a later stage of the 
work, but due to time constrictions it was not possible to complete the plan with this substract 
and understand the role of N-protecting group in the lactyl moiety insertion.  
The second step of the synthesis consisted on the silylation of O-6 positions of the N-
Phth derivative, and several silyl groups were tested, as shown in Figure 2.10. The aim was 
to understand if the bulkiness of the O-6 protecting group influences the lactyl moiety 
insertion and if it is possible to block some O-3 positions. In the literature it has been 
demonstrated that only the chitosan protection with TDBMSCl – was complete, DS = 1.0. 
Reported procedures for the chitosan protection with TBDPSCl mention DS of 0.82 but there 
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is no data for the protection with TPSCl. However, all 3 silyl groups were explored.62 At this 
point the data indicated that the chitosan derivate obtained possessed the O-3 position free, 
and was ready for the lactyl moiety insertion. Until this point the products isolated were 
characterized mainly with IR spectroscopy and compared with the literature results62 
concluding that this synthesis was effective until this point. Then we proceeded to the next 
synthetic step, lactyl moiety insertion, as will be further discussed. For the lactyl moiety 
insertion the first attempt was performed with 0.5 equiv. of (S)-2-chrolopropionic acid. This 
procedure has already been used in our group to introduce a lactyl moiety in glucosamine.20 
This first trial confirmed that with this strategy the lactyl moiety could be successfully 
introduce at the modified chitosan, which was confirmed by IR spectra analysis by the 
appearance of the carboxylic acid bands.  
(S)-2-chloropropionc acid was used in 2 and 4 equiv. for each O-3 position in 
alternate units, which effectively represents 1 and 2 equiv. of all O-3 positions, but for further 
reference we will designate as 2 and 4 equiv. of (S)-2-chloropropionic acid.  
The O-6-TBDMS derivative was in fact prepared, however in a preliminary stage it 
was decided to use groups with higher volume in order to prevent the lactyl moiety to be 
introduced in adjacent glucosamine units. So at this stage we focused only on the bulky 
protecting groups.  
In this procedure, Figure 2.12, NaH was used to form the sodium salt of the starting 
material making it soluble in DMF and also making it more nucleophilic. Since we had no way 
of quantify how many O-3 positions react it was not possible, at this stage, to determine the 
DS and also if the insertion was alternated or not.  
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Due to the fact that the O-silylation reaction was not complete, according to literature, 
DS<1.0, it suggested that some of the O-6 positions, which were not protected, could also 
react with (S)-2-chloropropionic acid. However, at this stage, there was no way of confirming 
alternate introduction of the lactyl moiety, which was evaluated later enzymatic studies.  
In the final stage of the silyl route to PGN’s sugar backbone, a set of reactions were 
executed, Figure 2.13, starting by the phthaloyl group removal, leaving the amine group free 
to be selectively acetylated. Subsequently, silyl group removal was performed, by using TBAF 
in pyridine. Due to the little amount of product obtained, to the product was directly used in 
the enzymatic studies. 
The IR showed to be a useful technique to analyze the silylated derivatives and 
monitor the reaction, once it was observed the decrease and shrinkage of the O-H band, 
3400-3450 cm-1, and also the appearance of the O-Si band. Some bands overlap in the 
region of the pyranose band at 1100-1000 cm-1, Figure 2.14. In the final step we make sure 
that the lactyl moiety was successfully insert by the 1668 cm-1 band, carboxylic acid band. 
Also in NMR CP/MAS spectra, Figure 2.15, it is noticed the change after O6-TBDPS 
Figure 2.14 IR spectra of polymeric chitosan modifications, black – (I.30); red – (I.32); dark green 
– (I.47); blue – (II.18); light green – (II.24) 
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protection, once the aromatic region, 134 – 122 ppm, changes by the appearance of a signal 
at 127.9 ppm relative to the two phenyl groups of TBDPS, also at the aliphatic region 40 – 20 
ppm, there is notice the appearance of a signal, 26,5 ppm relative to the terc-butyl group. 
After the lactyl moiety insertion step and the final steps of deprotection and acetylation, the 
final products were characterized by IR, unfortunately we still waiting for the NMR CP/MAS 
results.  
 
  
Figure 2.15 NMR CP/MAS spectra green I.32; black I.47; 
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2.2.2 Molecular clamp route 
Since the objective was to obtain alternate NAG-NAM sequences, without depending 
as much as we can of statistical insertion of the muramic acid moiety, the structure of the 
starting material was analysed - chitosan, to understand how could this problem could be 
overcome. Once the chitosan has a β-1,4 linkage, it means that every functional group 
position in the pyranose ring of an unit is the in the opposite position of the next unit, so in 
every odd unit the position of all functional groups are the same. With this idea we realized 
that if a linkage, such as a molecular clamp between two consecutive odd sugar units would 
create a blockage in the even unit placed between this two odd units, as shown in Figure 
2.16. In this case an esterification between two O6 positions was considered. However the 
chain length needed to link those positions was still to be determined.  
This strategy began with the design of a proper scaffold for the molecular clamp. A 
dicarboxylic acid was considered, in which the two O-6 positions could be linked. Suresh and 
co-workers reported the synthesis of dicarboxilic acids starting with different anhydrides and 
different ethylenoglycol derivatives.72 This work has inspired us to perform an estimation 
using Chem3D software in order to predict what should be the appropriate length of the 
ethylenoglycol chain in the molecular clamp. These studies suggested that a molecule with 
phthalic anhydride and diethylenoglycol should be enough for link two odd units in the N-Phth 
chitosan. Nevertheless three different dicarboxylic acids were synthesized, as shown in 
Figure 2.17.  
The purpose of its synthesis was to understand the role of the ethylenoglycol chain 
and also the role of the aromatic moiety.  
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The first step of this strategy or was the N-protection with phthalic anhydride and 1,2-
diphenyl maleic anhydride, giving the products I.32 and II.16, respectively. In fact the major 
variation between silylation route and molecular clamp route, is the O-6 esterification between 
two sugar units.  
 
To establish the protocol of diesterification, a reported procedure was adapted.72, 73 
However, different conditions were tested, starting with different coupling reagents, DIC or 
DCC. Despite the use of a large excess of TEA, those coupling reagents were no efficient 
enough to perform the reaction. Then CDI was used instead and proved to be a suitable 
reagent for this transformation.  
 
NMR CP/MAS and IR spectroscopy confirmed the molecular clamp moiety insertion, 
once it is shown in NMR CP/MAS spectra the variation in the aromatic region, 134 – 120 ppm 
after the molecular clamp moiety was insert, 129 ppm, a new signal related to molecular 
clamp moiety, once he work-up seemed to remove all the remaining molecular clamp that we 
used and did not react, Figure 2.19. Once the already describe problems were overcame with 
the procedure it was important to establish the stoichiometry of the molecular clamp to be 
used in order to promote the link between, two alternate glucosamine units.  
In a statistical approach to link every two alternate units the molecular clamp should 
be used for every four sugar units, leading to 25% (% mol) of molecular clamp of N-phthaloyl 
chitosan. So it was established to use two different amounts of molecular clamp understand 
the effect of the molecular clamp on the polymer structure. Thus 33% and 66% (% mol) of the 
Figure 2.19 NMR CP/MAS green I.32; black II.33 
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molecular clamp were tested. Since the product was only DMF soluble the reaction could not 
be follow the reaction by TLC, so the solvent was evaporated and then wash with ether to 
remove eventual molecular clamp residues. A yellow powder was obtained and characterized 
by NMR CP/MAS and IR.  
At this point it was important to understand the influence of molecular clamp moiety 
on the chitosan structure and check if the clamp used was able to confine the even position or 
not. To understand that the insertion of the lactyl moiety was tested disregarding the 
remaining free O-6 positions. 
  The procedure used to lactyl moiety insertion was the same procedure used 
previously in the silylation route. Starting with N-phthaloyl chitosan (I.32) and treating with 
66% of molecular clamp (II.30), compound II.34 was obtained.  After isolation, DMF 
evaporation followed by ether washing, to remove the remaining molecular clamp residues, 
and characterization, by NMR CP/MAS and IR, this compound II.34 was treated with 2 equiv. 
of (S)-2-chloropropionic acid, leading to the formation of II.41, Figure 2.20. Due to the 
problem of characterization we could not guarantee the SN2 reaction occur in the O-3 
position, or at the O-6 position that were not substituted. 
 In order to guarantee that only the O-3 positions were available for the lactyl moiety 
insertion, and understand the effect of the molecular clamp on the N-phthaloyl chitosan 
structure and its influence on O-3 positions, the remaining free O-6 positions were protected, 
Figure 2.21. The choice of the protecting group relied on the fact that only O-6 positions 
would be protected. Thus, TMS was not used because it was reported the reaction on 
chitosan O-3 positions. To make sure that every remaining O-6 positions were substituted 
Figure 2.20 Lactyl unit insertion in a chitosan derivative possessing some freeO-6 positions  
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with TBDMS, TBDMSCl was used in excess since it is known not to react on O-3 on N-
phthaloyl chitosan, guaranteeing that every O-6 positions were protected. 
 To conclude about the efficiency of the molecular clamp route, and the need or not of 
silytalion of the remain O-6 positions after the molecular clamp insertion, the lactyl moiety was 
introduced, Figure 2.24.  
 In this step the lactyl moiety insertion was performed in two different ways. The first 
method was the method already reproduced in the silylation route, 2 and 4 equiv. of (S)-2-
chloropropionic acid (SN2 reaction). The second method consisted on the activation of (S)-(-)-
2-hydroxypropionic acid ethyl ester, with triflic anhydride. This procedure had the goal of 
decrease the activation energy of the SN2 reaction, once the trifluoromethylsulfonyl group is a 
better leaving group than the chloride ion. The reaction proceeded with 4 equiv. of the (S)-2-
(((trifluoromethyl)sulfonyl)oxy)propanoic acid, to give the II.46 sample,. This approach, using 
the ester instead of the free carboxylic acid on the lactyl reagent implies more synthetic steps 
in the route towards the NAM-NAG. This approach involves the need to prepare the reagent 
in order to generate a more electrophilic reagent, and also the hydrolysis of the ester in a 
more advanced stage by treatment with LiOH.  
Figure 2.22 Muramic acid moiety insertion of O6 molecular clamp and O6-TBDMS N-phthaloyl 
chitosan 
O
O
O
O
O
O
O
O
O
HO
N
O O
HO N
OTBDMS
O
n
R2
R1
R1
R2
O
O
HO
N
O O
HO N
OTBDMS
O
R2
R1
R1
R2
DMF, rt, 48h
O
O
O
O
O
O
O
O
O
O
N
O O
HO N
OTBDMS
O
n
R2
R1
R1
R2
O
O
O
N
O
R1
R2
OR3
OOR
3
OR1, R2 = Phth
R1, R2 = Phth
R3 = H, OMe
(S)-2-Chloropropionic Acid or 
(S)-2-(((trifluoromethyl)sulfonyl)oxy)propanoic acid, 
NaH
II.42-43 II.44-46 
O
O
O
O
O
O
O
O
O
O
N
O O
HO N
OTBDMS
O
n
R2
R1
R1
R2
O
O
O
N
O
R1
R2
OR3
OOR
3
O
R1, R2 = Phth
R3 = H, OMe
Hydrazine
H2O, reflux, 24h
O
OH
O
H2N
O O
HO H2N
OTBDMS
O
n
O
OH
O
H2N
O
OH
OOHO
Acetic anhydride
Pyridine, rt, overnight
O
OH
O
HN
O O
HO HN
OTBDMS
O
n
O
OH
O
HN
O
OH
OOHO
O
O
O
TBAF
Pyridin, rt, overnigh
O
OH
O
HN
O O
HO HN
OH
O
n
O
OH
O
O
O
Figure 2.23 Sequence of deprotection and N-acetylation reactions 
II.44-46 
II.47-50 
 38 
 To complete the synthesis plan, a series of reactions were performed to remove the 
entire protecting groups and acetylate the amine. It was envisaged that the molecular clamp 
and the phthaloyl group could be removed at the same step by treatment with hydrazine, 
while the silyl groups could be easily removed by treatment with TBAF, Figure 2.23. 
 During the course of this polymeric chitosan modification, molecular clamp route, IR 
spectroscopy shown to be the best technique to follow reactions. As it is shown in Figure 
2.24, after molecular clamp moiety insertion, II.34, the IR spectra exhibited changes, 
specifically on the 1661 cm-1 band, which was then more intense than the 1716 cm-1 band of 
the I.32, leading us to conclude that the molecular clamp was successfully introduced. After 
this step, a silylation of the remaining O-6 positions was preformed achieving coumpond II.44. 
IR analysis of II.44 shows the shrinkage of the -OH band, 3467 cm-1 and the appearance of 
the O-Si bands 1067 and 998 cm-1. The next step was the introduction of the lactyl moiety, 
II.44. IR spectra shows the increase of the -OH band, and the enlargement of the 1800-1500 
cm-1 bands, leading to the appearance of the 1594 cm-1 band, probably due to the presence 
of carboxylic acid group. The final steps of this route consisted on protecting groups removal 
and acetylation of the free amine obtaining the II.48. In the IR spectra it can be observed a 
band at 1735 cm-1, corresponding to the carbonyl of the carboxylic acid, and 1663 cm-1 
corresponding to the carbonyl of the amide group. 
 Next step of the project consisted on the enzymatic studies in order to understand if 
the products obtained contained the NAM-NAG sequence and thus which strategy if any had 
been successful. .   
Figure 2.24 IR spectra of polymeric chitosan modifications, black (I.32); red (II.34); green (II.42); 
light blue (II.44); blue (II.48) 
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2.3 Enzymatic studies of the final products 
After the chemical modification of chitosan several products were obtained from the 
different strategies used. However, the characterization of these compounds revealed the 
presence of the lactyl moiety but it was not possible to determine the relative positions. Thus 
to analyse the sequence of the NAM and NAG units generated the enzymatic digestion 
appeared as a versatile and simple solution. Several enzymes are known to recognize the 
NAM-NAG sequence of the bacterial cell wall. Lysozymes hydrolyse the β-(1,4) glycosidic 
bond between the NAM and NAG in the natural substrate PGN.74 
Thus, in a first stage the enzymatic digestion was performed by the use of two 
different lytic enzymes, lysozyme and mutanolyzin, which hydrolyse between NAM and NAG 
units.  The experiments were carried under several conditions (for 24 and 92 hours) to 
understand the role of the time of reaction on the hydrolysis profile. Afterwards the products 
of hydrolysis were analysed by HPLC-UV, to a simple control and compared before and after 
hydrolysis. Additionally, HPLC-MS was used to identify the result of the hydrolysis. The 
affinity of the prepared samples for PGRP-SA was also evaluated in order to understand if the 
samples were recognized by these proteins. 
2.3.1 Enzymatic digestion  
The final products were digested with lysozyme and mutanolyzin to understand if 
there was any NAG-NAM sequence and also to compare with a natural source of PGN from 
E. coli. In a first attempt the products of the the silylation route, products, II.22-25, were tested 
together with the E. coli PGN, chitin and chitosan used as control. 
To monitor the experiments a negative control was conducted for every reactions, 
that consisted on the sample and buffer, without enzyme. The effect of the duration of the 
hydrolysis reaction, 24 and 92 hours was also tested.  
Table 2-2 summarizes the results obtained through HPLC-UV, where it can be 
observed that, lysozyme, as reported in the literature,39 recognizes and consequently is able 
to hydrolyse, chitin and chitosan, with almost the same hydrolysis profile as the synthetized 
products. This led to the conclusion that the N-acetyl moiety has no particular role in the 
recognition by the lysozyme. However the hydrolysis profile of products II.25, chitin and 
chitosan are quite different from the lysozyme hydrolysis of E. coli PGN. It was also observed 
that only one of the synthetic samples was hydrolysed by the lysozyme, which may indicate 
few facts. In the synthesis of the sample II.22 and II.23, the silyl group used, TPS was the 
bulkiest group that was used. The literature reports that the more bulky the lower the DS will 
be, TBDMS > TBDPS > TPS, and in fact the TBDPS group has a DS of 0.82, and TPS would 
have a DS around 0.70.62  
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Table 2-2 Summary of first enzymatic, lysozyme, digestion 
time (h) 
Sample 
24 92 
Chitin hydrolysed hydrolysed 
Chitosan hydrolysed hydrolysed 
II.22 
N.D. II.23 
II.24 
II.25 hydrolysed hydrolysed 
E. coli PGN hydrolysed hydrolysed 
The lower DS on the O-6 protection opens room for reaction with the (S)-2-
chloropropionic acid to occur at this position instead of the O-3, leading to a unit that could 
not be recognized by lysozyme, once the active site has no affinity to O-6 modifications, as 
already reported. The sample II.24 gave the same result and was not hydrolysed by the 
lysozyme. However its synthesis partner, II.25, was hydrolysed by lysozyme, giving a 
hydrolysis profile similar to chitin but with more peaks at 206 nm, as it is shown in Figure 
2.25. This may indicate that in some extent the sample II.25 managed to incorporate the 
NAG-NAM sequence in some positions that did not react with (S)-2-chloropropionic acid in 
the O-6 position, eventually due to the fact of using 4 equiv. of (S)-2-chloropropionic acid 
Figure 2.25 Comparison of lysozyme hydrolysis profiles, 206 nm absortion 
II.25+lysozyme 
II.25 
chitosan +lysozyme 
NAG-NAM 
E. coli + lyzozyme 
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unlike the II.24 2 equiv. were used In fact, not much difference was observed in the profile of 
the samples which hydrolysis was carried in 24 and 92 hours 
With these results in hand, the tests proceeded with all samples from the molecular 
clamp route. This time mutanolyzin was also used with these samples, with the exception of 
product II.47 that was only tested with lysozyme. Mutanolyzin has a larger active site and can 
hydrolyse PGN with an acetyl group at the O6-position, Staphylococcus aureus.75 
Table 2-3 Summary of the second enzymatic study (92 hours) 
Enzyme 
Sample 
Lysozyme Mutanolyzin 
Chitin 
N.D. 
hydrolysed 
II.25 N.D. 
II.47 hydrolysed Not tested 
II.48 
N.D. 
hydrolysed 
II.49 
N.D. 
II.50 
 
As Table 2-3 shows, in this second enzymatic study the results obtained were 
different from the results obtained in the first study. This fact suggested that maybe the 
lysozyme lost its activity, because it is not explainable how can chitin be at a first moment 
hydrolysed by lysozyme and at a second time only be by mutanolyzin. These experiments will 
have to be repeated to determine the exact lysozyme action on the substracts.  
Thus, due to the fact that only the 206 nm absorption was not enough to conclude 
what was the enzyme’s reaction on the sample, the enzymatic hydrolysis products were 
analysed by a MS detector, in order to understand the meaning of “hydrolysed”.   
Figure 2.26 Hydrolysis profile of II.48 treated with mutanolyzin; (green); (black) negative 
control, 206 nm absortion 
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The sample II.48 digested with mutanolyzin was analysed. Since the HPLC program 
was not the same, a study had to be done applying also the negative control to find out where 
was the difference in both chromatograms, Figure 2.27.  
Since the sample concentration was the same in both injections, it was possible to 
directly compare both of the chromatograms by the intensity. The observation of the negative 
control was important to ensure that the intensity during the HPLC run was not relevant so 
every peak that is present on the II.48+mutanolyzin chromatogram is derived of the 
mutanolyzin hydrolysis. To simplify the 
calculation of all combination of sugar unit, 
we developed an Octave program that 
reduced the chromatogram analysis time 
considerably. The code is shown in the 
section 6-Appendix. At retention time 8.18 
min it can be found, on MS spectra, a m/z 
499 peak, that represents a NAG-NAM 
unit plus one mass unit, since ESI+ was 
the ionization method. A peak of m/z 703 
is also present, which correspond to a 
oligomer of NAG-NAM-NAG plus two 
mass units, one derived of the ESI+ and 
the other only can be explain by the 
tolerance of the detection mode, one mass unit. The other peaks with retention times 12.48 – 
13.90 could not be assigned to any particular oligomer, but they might be peaks that are 
originated by the ionization of NAG-NAM sequences.  
Unfortunately due to the lack of product, we could not realize the HPLC-MS analysis 
of the sample II.47, and so we could not determinate its hydrolysis product.  
Figure 2.27 HPLC-UV/MS chromatogram of sample II.48; (red) II.48 + mutanolyzin; (green) 
negative control; 206 nm Absortion 
Figure 2.28 II.48 ESI+ MS, (8.18 min) 
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2.3.2 mCherry-PGRP pull-down assays 
Due to the ambiguous enzymatic hydrolysis results, and the loss of activity by the 
lysozyme, it was decided to preform several PGRP pull-down assays in order to check if this 
group of proteins could recognize the prepared samples. For this study a mCherry-PGRP-SA 
was used, PGRP-SA from D. melanogaster tagged with a N-terminal fluorescent tag that 
provides a pink colour to the protein. As already reported in Section1.2, PGRPs are 
responsible for the Gam-positive bacteria recognition, initiating the Toll pathway cascade. 
This protein family had conserved a 165-amino acid domain with an evolutionary connection 
to bacteriophage T7 lysozyme. PGRP-SA has the ability to recognise and bind to natural 
PGN.3, 76 PGRP-SA (PDB code 1SXR) has 80% query cover and 44% identify with the human 
PGRP-Iα (PDB code 1SK3_A) calculated with BLAST®. Until now there is no crystal structure 
of Drosophila PGRP-SA with any PGN moiety, NAG or NAM, so this experiment may be 
important to help to unravel the PGRP-SA recognition domain. In other PGRPs there seems 
to be an almost unchanged amino acid sequence responsible to, what seems to be the 
PGN’s sugar backbone interaction, and a sequence that may change, responsible for the 
peptide accommodation. However many studies claim that the peptide moiety is almost 
mandatory to the PGRP binding.8, 76, 77 
In this study several samples were tested, chitin, II.22-25, II.48, II.49 and II.50, 
divided in two types of experiment, a first experiment that consisted on a digestion in the 
presence of PGN, extracted from Staphylococcus aureus and a second one without PGN. In 
order to make sure that all the conclusions and assumptions were right several control 
samples were used: control sample, A – consisted on heating PGN in the reaction buffer; the 
control B – PGN reacted with LytA, in order to obtain the PGN’s sugar backbone as large as 
possible (to mimic synthetic samples); control C – PGN reacted with mutanolyzin, in order to 
obtain dimeric/crosslinked NAG-NAM units; and control D – consisted on a mixture of B and 
C, PGN that reacted with LytA and mutanolyzin, in order to obtain small soluble murein 
fragments, NAG-NAM.  
All of these control samples were boiled and centrifuged, and then the pellet was 
disposed. In the competition assays a reaction mixture was prepared as shown in 4.3.2. The 
BSA was used as internal loading control.  
 
Figure 2.29 8% SDS-PAGE gel electrophoresis of the mCherry-PGRP-SA pull-down 
assay in the presence of native PGN  
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Figure 3.30 shows the electrophoresis gel of the mCherry-PGRP-SA pull-down assay 
in the presence of natural PGN.  The synthetic samples were water-soluble and it was 
observed that once PGRP-SA binds to synthetic samples it forms a water-soluble complex. 
Once mCherry-PGRP-SA is also water-soluble, and a decrease of the intensity of mCherry-
PGRP-SA in the pellet was observed it suggested that a competition between the modified 
chitosan and the natural PGN could be taking place. That was supported by the direct 
observation of the electrophoresis gel, and also by the intensity of the bands, using ImageJ 
software. 
In Figure 2.30, is shown the percentage of the mCherry-PRGP-SA bounded to the 
chitosan derivative samples. Taking as 100% the assay where mCherry-PGRP-SA is 
incubated only with PGN, it is possible to observe that several samples have higher mCherry-
PGRP-SA intensity in the pellet than the 100% binding control. These samples that have a 
higher percentage of bingding than the native PGN have also a higher intensity of BSA in the 
pellet, which could indicate that BSA form some kind of complex with the synthetic samples 
that turns out to be insoluble. It was also observed that the control sample B, might form a 
soluble complex with mCherry-PGRP-SA, which explains the decrease the quantity of 
mCherry-PRGP-SA in the pellet. To understand these results it was decided to repeat the 
mCherry-PGRP-SA pull-down assay without the native PGN. 
Figure 2.32 shows the electrophoresis gels of the mCherry-PGRP-SA pull-down 
assays without the native PGN. This time it was not possible to define a 100% binding control 
sample, so the absolute values of mCherry-PGRP-SA intensity are shown, and quantified in 
Figure 2.32. From the obtaining results, there seems to be a disparity between both II.25 
values, so no efforts were concentrated in its analysis. On the other hand, samples II.48, II.49 
and II.50 seemed to be the samples that interact the best with mCherry-PGRP-SA. The chitin 
value seemed to be ambiguous once at the competition assay it did not increase the 
Figure 2.30 mCherry-PRGP-SA percentage of binding of the different samples in the mCherry-
PGRP-SA pull-down assay with native PGN 
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percentage of mCherry-PGRP-SA binding, and also as chitin is water-insoluble it was not 
possible to compare with the other results with water-soluble samples. 
At an initial stage of the experiments plan, it was envisaged that in a pull-down assay 
like this, the mCherry-PGRP-SA would be dragged to the pellet, since native PGN is 
insoluble. However, the results obtained seemed to contradict that thought. As the BSA 
intensity on the pellet increased, and has been reported the linkage of BSA to PGN and other 
sugars,78 it is not possible to assert that the synthetic samples form an insoluble complex with 
PGRP, leading to increase its intensity on the pellet. It is possible that the synthetic samples 
could form an insoluble complex with BSA and then drag the mCherry-PGRP-SA to the pellet. 
However, as the BSA intensity value is approximately the same in every control samples, in 
the completion and none-competition assays, the results strongly suggest that, the prepared 
samples effectively drag the mCherry-PGRP-SA to the pellet, indicating an affinity to this 
protein. 
Figure 2.32 8% SDS-PAGE gel electrophoresis of the mCherry-PGRP-SA pull-down assay 
without native PGN  
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Figure 2.31 mCherry-PGRP-SA intensity in the PGRP-SA pull-down assay without native 
PGN 
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At this point the results indicated that the mechanism of mCherry-PRGP-SA 
recognition was mainly related with the sugar backbone and not so much with the peptide 
moiety. Once the control sample B seemed to be one that most dragged mCherry-PGRP-SA 
to the pellet and sample B has a long chain only composed by NAG-NAM units, might be that 
the peptide moiety leads to lower kD value. However the interaction between the prepared 
samples and mCherry-PRGP-SA seemed to be quite strong, since it did not broke up during 
the preparation steps before it was applied on the gel. 
The analysis of the mCherry-PGRP-SA pull-down assays seemed to contradict some 
of the previous enzymatic digestion results. In order to clarify the real composition of the 
prepared samples it was decided to do a last study using other technic that could help in 
understanding whether the products prepared on this journey would led to the NAM-NAG 
polymer. 
2.3.3 Monosaccharide composition analysis 
To finish the product analysis studies, and be able to bring up some conclusions 
about the research, a monosaccharide composition analysis was performed, This study 
consists on hydrolysing the prepared samples, with 3 M HCl for 3 and 24 hours according to 
procedure 4.3.3. Two different times of hydrolysis were used, since this protocol was 
optimized to monosaccharide composition analysis of native PGN. In this procedure an 
anionic exchange chromatography was used, with a pH electrode as detection method. This 
allowed to conclude how much of every monosaccharide was present in the prepared 
sample. Due to the chemical hydrolysis, the monosaccharides NAG originate glucosamine 
moieties while the NAM hydrolysis gives muramic acid. By the chromatograms analysis it was 
possible to conclude that 3 hours of hydrolysis were enough to convert the synthetic samples 
into monosaccharides.  
For this experiment the concentration of the monosaccharides was calculated using a 
calibration curve, which was made using several concentrations of ribitol, glucosamine, 
Figure 2.33 Muramic acid: Glucosamine ratio 
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muramic acid and NAM. The results were obtained by the direct integration of the peak’s area 
in the chromatogram and are summarized in Figure 2.33. 
  The analysis of the muramic acid-glucosamine ratio obtained for the synthetic 
samples indicated that the low ratio in the sample II.25 might be related with the DS of the 
TBDPS group as already was a concern. On the other hand the low ratio of the sample II.50 
may be related with the reaction conditions and reagent used to insert the lactyl moiety that 
was not suitable to chitosan reaction. The strategy to insert the lactyl moiety in the samples 
II.48 and II.49 was the best that has been embraced. Since sample II.48 was only recognized 
by mutanolyzin, and as a monosaccharide ratio similar to S. aureus, it is suspected that 
maybe, in the acetylation procedure the acetic anhydride could also reacted with the O-6 
position. This acetyl group would be removed during the chemical hydrolysis step providing 
muramic acid unit. However as the sample II.25 was only recognized by lysozyme in the first 
try, and has a significant ratio, reinforced the lost of lysozyme activity observed.  
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3 Conclusions and final remarks 
Since bacterial peptidoglycan is directly associated with bacterial infections and 
antibiotic resistance, this work contributed to a new and sustainable access to the 
carbohydrate backbone of the peptidoglycan. 
The scientific community has devoted several efforts to the synthesis of bacterial 
peptidoglycan however these approaches involve long synthetic sequences and laborious 
isolation. Additionally peptidoglycan isolation in pure and reliable amounts from the bacterial 
cell-wall is difficult and the presence of contaminations can lead to controversial results.  
Thus, in this work a new approach has been explored using a biopolymer, chitosan 
as the starting material to produce artificial NAM-NAG polymer. In a preliminary study 
chitosan was hydrolyzed, and several reaction conditions and procedures were tested to 
obtain chitooligosaccharides of controlled molecular weight. The best conditions involved 
treatment with concentrated acid and chitooligosaccharides of DP2–15 were obtained and 
characterized by MALDI-TOF and GPC. 
Using the food industry disposal, chitosan, two synthetic strategies were adopted: 
regioselective O-6 protection with silyl groups – silylation route and di-esterification at two 
alternate O-6 positions – molecular clamp route. 
In the silylation route two different protecting groups were tested in order to generate 
different steric hindrance, TBDPS and TPS. The introduction of the lactyl moiety was also 
investigated and several experiments were carried to optimize this step. Best results were 
obtained when 2 equiv. of (S)-2-chloropropionic acid was used. The reactions were monitored 
by IR and the products characterized by IR and CP-MAS NMR.  
In the molecular clamp route, several molecular clamp scaffolds were prepared, 
however only one could be tested. For the lactyl moiety insertion the strategy followed the 
same procedure as described for the silylation route. After the lactyl group had been 
introduced in both approaches, the protecting groups were removed and the free amino group 
was acetylated. The final compounds were characterized by IR and NMR spectroscopy. 
The isolated products were then hydrolyzed with lysozyme and mutanolyzin and 
analysed by HPLC-UV, in order to evaluate the content of NAM-NAG moieties on these 
samples. These studies seemed inconclusive to the majority of the samples with the 
exception of II.48 that provided a different HPLC profile before and after mutanolyzin 
hydrolysis. HPLC-MS analysis showed the presence of two characteristic peaks at m/z 499 –
and m/z 703, consistent with NAG-NAM and NAG-NAM-NAG, respectively. The NAG-NAM 
content of these samples was also evaluated through chemical hydrolysis and ion 
chromatography exchange. A 1:1.18 ratio was obtained for the sample II.48, very close to the 
composition of the natural PGN extracted from S. aureus’s, 1:1.2. 
Apart from that a mCherry-PGRP-SA pull-down assay was also preformed in order to 
understand the affinity of mCherry-PGRP-SA to these synthetic samples. It was proved that 
mCherry-PGRP-SA had affinity to these synthetic samples. 
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These analyses suggested that the molecular clamp route is the best strategy to 
convert chitosan into NAM-NAG polymer, in which a careful choice of the reaction conditions 
and reagents is the key to achieve the optimized conversion.  
Using this study as preliminary results, the next step consists on optimizing the 
chitooligomers isolation process, and generates NAG-NAM murein oligomers.  After peptide 
coupling, PGN fragments will be generated and constitute valuable artificial samples of PGN 
for the in vivo studies, in order to conclude if the synthetic PGN fragments will be able to 
produce an immune response in D. melanogaster. 
Chitosan has demonstrated to be a good model to achieve artificial NAM-NAG 
oligomers. This work opens a new platform for achieving PGN fragments with different 
composition and thus useful for innumerous biological studies.  
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4 Experimental procedure  
4.1 General Methods 
All commercially obtained reagents were used without further purification unless 
specified. All the mentioned solvents used in the reactions were dried by usual methods.79 
Molecular sieves 4Å were activated by heating at 300 ºC for 3 h. Preparative and 
analytical TLC was performed with silica gel 60 plates of 1 mm, 0.5 mm and 0.25 mm, 
respectively. The reactions that could be followed by thin layer chromatography (TLC) silica 
gel 60 G/UV254 Macherey-Nagel with 0.20 mm Spots detection on TLC was carried with UV 
light using a 254 nm lamp (Vilber-Lourmat). Aditionally, TLC plates visualization was carried 
with a TLC spray solution of ethanol-sulfuric acid 9:1. 
Nuclear Magnetic Resonance (NMR) spectra were recorded at Brüker Advance 400 
MHz for 1H and at 100 MHz for 13C, in CDCl3, DMSO-d6, D2O or CDCl3 with chemical shift 
values (δ) in ppm downfield from TMS (0 ppm) or the solvent residual peak of D2O (4.79 
ppm), DMSO-d6 (2.50 ppm) or CDCl3 (7.24 ppm) as internal standard. The chemical shifts (δ) 
for a proton spectra were expressed in parts per million (ppm) and the data for proton spectra 
was presented in the following order: deuterated solvent, signal chemical shift (δ), relative 
intensity, spin multiplicity (s –singlet, d – doublet, t – triplet, m – multiplet, dd – doublet of 
duplets), coupling constant (J, in Hz) and molecule peak attribution if possible. The data for 
carbon spectra was presented in the following order: solvent, chemical shift (δ), molecule 
attribution if possible. CP MAS - NMR experiments were  acquired in 
a Spectrometer  BRUKER AVANCE 400 spectrometer operating at  9.4 T magnetic field 
(ultrashielded) at Universidade de Aveiro through the PTNMR network service. The mass 
spectra were obtained on a Micromass AutoSpecQ and a Micromass GTC (MALDI-TOF-MS, 
Matrix: 2,5-dihydroxybenzoic acid at the chemistry department at FCT-UNL. 
 Infrared (IR) spectra were recorded on a Brücker Tensor 27 spectrophotometer FTIR 
spectra were recorded on Perkin-Elmer Spectrum 1000 model apparatus in KBr dispersions 
for solid samples or NaCl dispersions for oil samples. In each spectra description were only 
identified the more intense and characteristic bands. The data obtained is presented in the 
following order: sample support (NaCl or KBr); frequency of the maximum absorption band 
(νmax in cm-1attribution to a functional group in a molecule if possible.  
Chitosan 80+ low molecular weight was purchased from AltaKitin. 
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4.2 General procedures for chitosan modification 
4.2.1  Chitosan hydrolysis 
 
Table 4-1 Summary of the hydrolysis’ work 
Entry 
Concentration 
mg/mL 
 
Time 
(h) Conditions Acid 
Results ª,b 
DA 
(%) n 
Mn 
(Da) 
Mw 
 (Da) PDI 
1 
10  
 
 
 
6 Ultrasound bath 
5%  
acetic 
acid 
Nothing occur 2 4 
Ultrasound 
probe 
3 6 Ultrasound probe 
4 40  6 Ultrasound bath 1M HCl 
N. D. 
5 
20  
0.5 - 1 
72ºC 12M HCl 
6 3 12 2-18 729 1002 1.37 
7 4  2-16    
8 5 11 2-15 674 860 1.28 
 
4.2.1.1 General procedure for chemical hydrolysis  
To a 100 mL HCl 12 M solution was added 2 g of chitosan, previously dissolved in a 
solution of 5% acetic acid to form a gelatin. The suspension was stirred for a period of time as 
shown in Table 4-1 in a bath at 72°C. The reaction was quenched by addition of ice water and 
left with stirring for a few minutes. The brown solution obtained was evaporated to dryness, 
then dissolved in 100 mL of distilled water, and concentrated under vacuum. These 
operations were repeated twice so as to remove the large amount of HCl.48  
Product isolation: 
1. The product was then dissolved in water, and the pH adjusted to 3 with 
concentrated NaOH in a flask maintained below 20 °C with an ice bath. The 
mixture was applied in a dialysis membrane of cellulose ester (CE) with a 
molecular weight cut off of 500 – 1.000 Da overnight and dialyzed in 1 L 
Figure 4.1 Schematic representation of hydrolysis reactions 
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HO NH2
O
O
HO NH2
OH
OH
R= H
R= Ac (18%)
n
ª The acetylation degree was calculated based on equation 1; b the n, Mn, Mw and DPI (Mw/Mn) were calculated 
trough MALDI-TOF analysis  
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distilled water. The water was renewed and allowed to dialyze for 24 hours. 
The combined aqueous layers were then concentrated under vacuum and 
finally were lyophilized.  
2. The product was treated with 200 mL of cold acetone, and a white powder 
precipitated. The powder was filtered and dried to give a beige solid  
 
4.2.2 Chitosan N-protection 
To a solution of 5.6 mmol of the anhydride in 6 mL of DMF containing 5% of water 
was added 0.3 g (1.89 mmol) of chitosan, and the mixture was heated under a nitrogen 
atmosphere at 120ºC with stirring, over night. The reaction mixture was cooled then poured 
into ice water. The precipitate was collected on a filter, washed with 150 mL of methanol for 
one hour and dried to give the product.  
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Figure 4.2 Schematic representation of N-protection reactions 
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I.32 starting with commercial chitosan 20% DA using the 4.2.2 
procedure. A dark tan solid was obtained 72% yield. 
13C CP/MAS NMR (101 MHz; None): δ 168.8 (C=O), 134.5, 
130.9, 123.1 (Ar), 100.6 (C1), 82.3 (C4), 75.0 (C5), 71.0 (C3), 
60.9 (C6), 56.3 (C2). 
IR νmax(KBr): 3446 (O-H), 2928 (N-H), 1773 and 1717 (C=O), 
1641 (C=O), 1196-990 (C-O) cm-1. 
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1-14O
O
O
O
II.10 starting with II.8 using the procedure 4.2.2. A tan pale 
powder was obtained in 87% yield. 
1H-NMR (400 MHz; DMSO-d6): δ 8.03-7.74 (m, 4H), 5.44-5.00 
(m, 2H), 4.75 (s, 1H), 4.23 (m, 3H), 3.72 (s, 2H), 2.91 (s, 1H). 
MALDI-TOF: m/z 331 [DP1+Na+]; 623,21 [DP2+Na+]; 914,29 
[DP3+Na+]; 1205,37 [DP4+Na+]; 1496,44  [DP5+Na+] 
II.8 Starting with commercial chitosan 20% DA using the 4.2.1.1 
procedure. An off-white powder was obtained in a yield of 92.5%. 
1H-NMR (400 MHz; D2O): δ 5.37 (t, J = 3.2 Hz, 0.25H), 4.90-4.76 (m, 1H), 
3.97 (t, J = 9.5 Hz, 0.344H), 3.89-3.59 (m, 5H), 3.50-3.38 (m, 1H), 3.25 (m, 
0.32H), 3.12-3.04 (m, 1H), 3.00-2.91 (m, 0.2H), 1.83-1.80 (m, 0.386H). 
MALDI-TOF: m/z 363.19 [DP1+Na+]; 524.30 [DP2+Na+]; 685.39 
[DP3+Na+]; 846.49 [DP4+Na+]; 1007.58 [DP5+Na+]; 1168.67 [DP6+Na+]; 
1329.75 [DP7+Na+]; 1490.83 [DP8+Na+]; 1651.92 [DP9+Na+]; 1812.97 
[DP10+Na+]; 1974.04 [DP11+Na+]; 2135.13 [DP12+Na+]; 2296.17 
[DP13+Na+]; 2457.30 [DP14+Na+]; 2779.40 [DP15+Na+]. IR νmax(KBr): 
3400 (O-H), 2949 (N-H), 1631 (NHC=O), 1151-1020 (C-O) cm-1. 
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4.2.3 Chitosan O6-protection 
4.2.3.1 Molecular Clamp route 
4.2.3.1.1 Molecular Clamp synthesis 
  To a solution of anhydride (15.0 mmol) in 100 mL of anhydrous DCM, was added the 
diol (5.0 mmol) and stirred for 10 minutes, under a nitrogen atmosphere. The reaction mixture 
Figure 4.3 Schematic representation of molecular clamp synthesis 
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II.9 starting with II.8 using the procedure 4.2.2. An orange 
powder was obtained in 44% yield. 
1H-NMR (400 MHz; aceton-d6): δ  7.55-7.37 (m, 9H), 7.13-7.00 
(m, 1H), 6.10-6.07 (m, 0.16H), 5.34-5.26 (m, 1H), 4.87-4.79 (m, 
0.5H), 4.52-4.35 (m, 1H), 4.05-3.99 (m, 1H), 3.71-3.68 (m, 2H). 
IR νmax(KBr): 3437 (O-H), 3063, 1760, 1716, 1659 (C=O), 1581 
(Ar), 1151-1010 (C-O) cm-1. 
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II.16 starting with commercial chitosan 20% DA 4.2.2. A tan 
yellow powder was obtained in 80% yield.  
13C CP/MAS NMR (101 MHz; None): δ 170.9 (C=O), 136.4, 
128.7 (aromatic), 100.0 (C1), 82.6 (C4), 74.6 (C5), 69.9 (C3), 
60.4 (C6), 56.4 (C2). 
IR νmax(KBr): 3446 (O-H), 3066, 1769, 1706, 1652 (C=O), 1575 
(Ar), 1154-1018 (C-O) cm-1. 
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was cooled to 0ºC and 15 mmol of anhydrous TEA was added drop-wise. The reaction was 
stirred overnight at room temperature. The solvent was evaporated, and the residue obtained 
cooled to 0ºC and 200 mL of saturated sodium bicarbonate solution was added. The aqueous 
layer was washed with ether, 3 x 100 mL. The aqueous layer was collected and cooled to 
0ºC, acidified with diluted HCl 1 M and extracted with DCM (4 x 100 mL). The combined 
organic layers were evaporated and dried under reduced pressure to provide the 
correspondent pure dicarboxiyic acid.72 
 
 
 
4.2.3.1.2 Molecular Clamp insertion 
   
The dicarboxylic acid (x mmol) was dissolved in 3 mL of anhydrous DMF and with 
CDI was added (2x mmol) in, under a nitrogen atmosphere and the mixture was stirred at 
room temperature for 3 hours. The mixture was added drop-wise to a solution of I.32 (350 
mg,1.2 mmol) and TEA (1.136 mL, 8.16 mmol) in 4 mL of anhydrous DMF, at room 
temperature under nitrogen atmosphere and the resulting mixture was stirred for 24 hours. 
The solvent was removed to dryness and the resulting crude washed t with 5 mL of methanol 
in an ice bath, to obtain a yellow solid.  
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II.30 starting with phthalic anhydride and diethylenoglycol 
using the procedure 4.2.3.1.1. A colerless oil was obtained in 
90% yield. 
1H-NMR (400 MHz; CDCl3): δ 7.80-7.57 (m, 8H), 4.43 (t, J = 
3.4 Hz, 4H), 3.77 (t, J = 3.3 Hz, 4H). 13C NMR (100 MHz; 
CDCl3): δ 174.7, 167.9, 132.3, 131.9, 131.58, 131.46, 131.0, 
129.49, 129.39, 128.9, 69.3, 65.8. IR νmax(NaCl): 3054 (O-H), 
1726, 1702 (C=O), 1172-1077 (C-O) cm-1. 
II.31 starting with 1,2-Diphenyl maleic anhydride and 
triethylenoglycol using the procedure 4.2.3.1.1. A yellow 
powder was obtained in 89% yield. 
1H-NMR (400 MHz; CDCl3): δ 7.55-7.39 (m, 24H), 3.75 (t, J 
= 4.3 Hz, 4H), 3.69 (s, 4H), 3.63 (t, J = 4.3 Hz, 4H). IR ν
max(KBr): 3390 (O-H), 1842, 1823, 1758, 1629 (C=O), 1180-
1000 (C-O) cm-1. 
 
II.32 starting with 1,2-Diphenyl maleic anhydride and 
diethylenoglycol using the procedure 4.2.3.1.1. A yellow 
powder was obtained in 64% yield. 
1H-NMR (400 MHz; CDCl3): δ 7.58-7.41 (m, 20H), 3.73 (dt, J 
= 57.2, 4.4 Hz, 8H). 13C-NMR (100 MHz; CDCl3): 164.81, 
138.17, 131.14, 129.69, 128.93, 127.18, 72.26, 61.87. IR ν
max(KBr): 3390 (O-H), 1834, 1821, 1755, 1638, 1599 (C=O), 
1178-995 (C-O) cm-1. 
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Figure 4.4 Schematic representation of molecular clamp insertion 
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II.33 starting with I.32 and 33%(% mol) of II.30, using 
4.2.3.1.2 procedure. A yellow powder was obtained, 
289 mg. 
13C CP/MAS NMR (101 MHz; None): δ 173.4 (C=O 
amide), 169.0 (C=O ester), 134.7, 130.7, 123.3 (Ar), 
100.4 (C1), 82.4 (C4), 74.9 (C5), 70.3 (C3), 64.8 (-
OCH2), 61.1 (C6), 56.1 (C2). IR νmax(KBr): 3446 (O-H), 
2972, 2880 (C-H Ar), 1775, 1712, 1650 (C=O), 1563 
(Ar), 1471, 1392, 1295 (C-O ester), 1194-966 (C-O) 
cm-1. 
II.34 starting with I.32 and 66%(% mol) of II.30, using 
4.2.3.1.2 procedure. A yellow powder was obtained, 
320 mg. 
13C CP-MAS NMR (101 MHz; None): δ 172.7 (C=O 
amide), 168.7 (C=O ester), 134.6, 130.4, 123.3 (Ar), 
100.3 (C1), 83.1 (C4), 74.7 (C5), 70.5 (C3), 65.4 (-O-
CH2), 60.8 (C6), 55.9 (C2). IR νmax(KBr): 3428 (O-H), 
2924, 2860 (Ar), 1771 (C=O), 1387, 1289 (C-O ester), 
1196-974 (C-O) cm-1. 
 
 
II.29 starting with I.32 and 33%(% mol) of II.32, using 
4.2.3.1.2 procedure. A yellow powder was obtained, 
298 mg. 
IR νmax(KBr): 3445 (O-H), 2973 (C-H AR), 1828, 1773, 
1758, 1716, 1654 (C=O), 1599, 1560 (Ar), 1469, 
1445, 1392, 1354, 1275 (C-O ester), 1194-966 (C-O) 
cm-1. 
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II.35 starting with I.32 and 66%(% mol) of II.32, using 
4.2.3.1.2 procedure. A yellow powder was obtained, 
317 mg. 
13C CP/MAS NMR (101 MHz; None): δ 172.4 (C=O 
amide), 168.6 (C=O ester), 134.4, 130.5, 126.3, 123.1 
(Ar), 100.3 (C1), 82.8 (C4), 74.5 (C5), 70.8 (-O-CH2), 
70.1 (C3), 65.6 (-COO-CH2) 60.9 (C6), 56.2 (C2). IR 
νmax(KBr): 3422 (O-H), 2925 (Ar), 1824, 1773, 1758, 
1712, 1655 (C=O), 1444, 1390, 1356, 1275 (C-O 
ester), 1180-998 (C-O) cm-1. 
II.36 starting with I.32 and 33%(% mol) of II.21, using 
4.2.3.1.2 procedure. A yellow powder was obtained, 263 
mg. 
IR νmax(KBr): 3445 (O-H), 2925 (C-H Ar), 1775, 1714, 
1650 (C=O), 1556 (Ar), 1469, 1392, 1318, 1295 (C-O 
ester), 1196-992 (C-O) cm-1. 
II.37 starting with I.32 and 66%(% mol) of II.31, using 
4.2.3.1.2 procedure. A yellow powder was obtained, 299 
mg. 
13C CP/MAS NMR (101 MHz; None): δ 173.3 (C=O 
amide), 168.7 (C=O ester), 134.6, 130.5, 123.2 (Ar), 
100.3 (C1), 82.4 (C4), 74.7 (C5), 71.9 (-O-CH2), 70.3 
(C3), 64.6 (-COOCH2), 60.7 (C6), 56.1 (C2). 
IR νmax(KBr): 3447 (O-H), 2924 (C-H Ar), 1830, 1771, 
1709, 1654 (C=O), 1467, 1385, 1329, 1277 (C-O ester), 
1196-939 (C-O) cm-1. 
II.38 starting with II.16 and 33% (% mol) of II.30 , 
using 4.2.3.1.2 procedure. A yellow powder was 
obtained, 273 mg. 
13C CP/MAS NMR (101 MHz; None): δ 170.9 (C=O 
amide), 134.1, 128.9 (Ar), 100.5 (C1), 81.7 (C4), 
74.8 (C5), 70.0 (C3), 64.8 (-COOCH2), 60.8 (C6), 
56.6 (C2). IR νmax(KBr): 3446 (O-H), 1767, 1705, 
1656 (C=O), 1152-1018 (C-O) cm-1. 
II.39 starting with II.16 and 66% (% mol) of II.30, 
using 4.2.3.1.2 procedure. A yellow powder was 
obtained,  342 mg. 
13C CP/MAS NMR (101 MHz; None): δ 170.8 (C=O 
amide), 164.7 (C=O ester), 136.0, 128.9 (Ar), 100.1 
(C1), 82.6 (C4), 74.5 (C5), 69.6 (C3), 65.2 (-
COOCH2), 60.0 (C6), 56.1 (C2). IR νmax(KBr): 3446 
(O-H), 1767, 1705, 1652 (C=O), 1599 (Ar), 1151-
980 (C-O) cm-1. 
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4.2.3.1.3 O6 remaining groups Silylation  
In order to guaranty that every remaining O6 positions became protected we use as 
much equivalents of the silyl chloride as the N-phthaloylchitosan, so the protocol followed was 
the same as the 4.2.3.2. 
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Figure 4.5 Schematic representation of the protection of the remaining O6 free positions 
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II.42 starting with II.34 using the procedure 4.2.3.2. A 
yellow powder was obtained, 396 mg. 
IR νmax(KBr): 3466 (O-H), 1778, 1729, 1646 (C=O), 
1471, 1390, 1326 (C-O ester), 1196-970 (C-O), 1119, 
1071 (Si-O) cm-1. 13C NMR CP/MAS (101 MHz; None): 
δ 172.3 (C=O amide), 168.2 (C=O ester), 148.0, 134.4, 
131.8, 123.6, 116.8 (Ar), 99.2 (C1), 83.2 (C4), 82.4 (-O-
CH2), 75.2 (C5), 71.0 (C3), 63.4 (C6), 55.9 (C2), 25.5 
(C(CH3)3), -6.0 (CH3) 
II.43 starting with II.33 using the procedure 4.2.3.2. A 
yellow powder was obtained,  351 mg. 
IR νmax(KBr): 3460 (O-H), 1755, 1718, 1664 (C=O), 
1467,1389, 1322 (C-O ester), 1194-966 (C-O), 1115, 
1066 (Si-O) cm-1.  
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4.2.3.1.4 Muramic Acid moiety insertion 
4.2.3.1.4.1 Reaction with (S)-2-Chloropropionic  
 In this reaction was followed the procedure described in 4.2.4. 
 
 
 
O
O
O
O
O
O
O
O
O
O
N
O O
HO N
OR3
O
n
R2
R1
R1
R2
O
O
O
N
O
R1
R2
OH
OOHO
R1, R2 = Phth
R3 = TBDMS
O
O
O
O
O
O
O
O
O
O
N
O O
HO N
OR3
O
n
R2
R1
R1
R2
O
O
O
N
O
R1
R2
OH
OOHO
R1, R2 = Phth
R3 = TBDMS
O
O
O
O
O
O
O
O
O
O
N
O O
HO N
OR3
O
n
R2
R1
R1
R2
O
O
O
N
O
R1
R2
OH
OOHO
R1, R2 = Phth
R3 = H
II.44 starting with II.42 and 2 equiv. of (S)-2-
Chloropropionic acid using the procedure 4.2.4. A yellow 
powder was obtained, 218 mg.  
IR ν max(KBr): 3422 (O-H), 2957, 2924, 2854 (C-H 
alkane), 1722-1640 (C=O), 1458, 1259, 1208 (C-O 
ester), 1090-990 (C-O), 1070 (Si-O) cm-1. 
II.45 starting with II.42 and 4 equiv. of (S)-2-
Chloropropionic acid using the procedure 4.2.4. A yellow 
powder was obtained, 239 mg.  
IR ν max(KBr): 3422 (O-H), 2953, 2924, 2854 (C-H 
alkane), 1712-1609 (C=O), 1458, 1399 (C-O ester) 
1148-988 (C-O), 1081 (Si-O) cm-1. 
II.41 starting with II.34 and 2 equiv. of (S)-2-
Chloropropionic acid using the procedure 4.2.4. A yellow 
powder was obtained, 223 mg.  
IR νmax(KBr): 3435, 3286, 3176 (carboxylic acid), 2961 
(alkane), 1706, 1639 (C=O), 1567, 1415 (Ar), 1338, 
1247 (C-O ester) 1109-998 (C-O) cm-1. 
Figure 4.6 Schematic representation of muramic acid moiety insertion 
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4.2.3.1.4.2 Reaction with hydroxypropionic acid ethyl ester 
To a solution of (S)-(-)-2-hydroxypropionic acid ethyl ester (186,27 µl, 1,62 mmol) 
dissolved in dried DCM was added 2,6-lutidine (188,77 µl, 1,62 mmol), under inert 
atmosphere, and the mixture was cooled to -78ºC. Then triflic anhydride (270 µl, 1,62 mmol) 
was added. The mixture was stirred and the mixture was allowed to warm-up to room 
temperature. The mixture was diluted with 10 mL of a 1:1 mixture hexane:DCM and filtered 
through celite. The filtrate was concentrated in the vacumm to afford a yellow oil.  
This product was used in the general procedure described in 4.2.4. instead of (S)-2-
Chloropropionic acid. 
 
 
 
 
4.2.3.1.5 Protective groups removal and N-acetylation 
 
4.2.3.1.5.1 Phthaloyl group and molecular clamp removal 
1. In order to guaranty that all of the phthaloyl and molecular clamp groups were 
removed we used huge excess, 40 equiv. of hydrazine monohydrate in 
boiling water, in a concentration of 6 M, for 24 hours. Then the solvent was 
evaporated an washed with 5 mL of distilled water, 5 mL of ethanol and 5 mL 
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II.46 starting with II.43 and 2 equiv. of (S)-(-)-2-
hydroxypropionic acid ethyl ester using the procedure 4.2.4. A 
yellow powder was obtained, 304 mg. 
IR νmax(KBr): 3448 (OH), 2961 (alkane), 1777, 1718, 1663 
(C=O), 1391 (C-O ester) 1169-1033 (C-O) cm-1 
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Figure 4.7 Schematic representation of protecting group removal and and N-acetylation reaction 
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of ethyl ether. The product was not characterized and was all used in the N-
acetylation procedure to avoid loss of material. 
2. For II.46, the compound was dissolved in 4,5 mL of distilled water and 4,5 mL 
of dioxane, and to this solution was added lithium hydroxide monohydrate (66 
mg,1.57 mmol) at room temperature for 2 h30 min. The reaction was 
quenched by adding a HCl 1 M solution and the pH adjusted to 3. , The 
solvent was removed and the crude obtained was washed with 1 mL of 
water, followed by evaporation of solvent. The residue obtained was washed 
with ethyl ether (2 x 2 mL). The product obtained was not further purified and 
was used directly in the next step. 
4.2.3.1.5.2 N-acetylation 
The N-acetylation was performed according to the procedure described in 4.2.5, 
without work-up, proceeding to the silyl group removal one pot.  
4.2.3.1.5.3 Silyl group removal 
In order to remove all the silyl groups add 2 equiv. of a solution of TBAF 1 M in THF. 
The mixture was stirred overnight at room temperature. The solvent was removed, and the 
dry crude was washed with ethyl ether (x mL) and distilled water (1 mL) and 0.1 mL of NaOH 
1 M were added. The water was evaporated and the residue taken to dryness. To the 
resulting residue was addeddistilled water (1 mL) and the pH adjusted to 3 with a solution of 
HCl 1 M. The water was evaporated to give a product. 
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II.47 starting with II.41 followed by the sequence of deprotection procedures 
4.2.3.1.5. A yellow powder was obtained, 59 mg. 
IR νmax(KBr): 3434 (O-H), 3014, 1732, 1702, 1655 (C=O), 1152, 990 (C-O) 
cm-1. 
II.48 starting with II.44 followed by the sequence of deprotection procedures 
4.2.3.1.5. A yellow powder was obtained, 167 mg. 
IR νmax(KBr): 3447 (O-H), 1736, 1663 (C=O), 1162-1009 (C-O) cm-1. 
II.49 starting with II.45 followed by the sequence of deprotection procedures 
4.2.3.1.5. A yellow powder was obtained, 179 mg. 
IR νmax(KBr): 3435 (O-H), 1698, 1656 (C=O), 1158-1012 (C-O) cm-1. 
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4.2.3.2 Silylation route 
 
 To a suspension of N-phtaloylchitosan (0.3 g, 1.05 mmol) and an excess of 
imidazole (0.581 g, 8.53 mmol) in anhydrous DMF (40 mL) was treated with the respective 
silyl chloride group in different excess, TBDMSCl (1.14 g, 7.61 mmol), TBDPSCl (1.95 mL, 
7.53 mmol), TPSCl (1.45 g, 4.95 mmol). The reaction was stirred at room temperature for 72 
hours. The product was precipitated with 50 mL of water/ethanol (1:1 v/v) solution. Then the 
solid was filtered and washed with 20 mL of water/ethanol and ethyl ether 3 x 5 mL.62 
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Figure 4.8 Schematic representation of silylation of N-protected chitosan 
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I.47 starting with I.32 and TDBMSCl, using 4.2.3.2. A white powder was 
obtained, 398 mg.  
IR νmax(KBr): 3435 (O-H), 1779, 1708 (C=O), 1197-963 (C-O) 873 (Si-O) 
cm-1. 
II.50 starting with II.46 followed by the sequence of deprotection procedures 
4.2.3.1.5. A yellow powder was obtained, 194 mg. 
IR νmax(KBr): 3429 (O-H), 1717, 1651, 1635 (C=O), 1151-1029 (C-O) cm-1. 
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4.2.3.2.1 Lactyl moiety insertion 
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Figure 4.9 Schematic representation of lactyl moiety insertion 
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I.47 starting with I.32 and TDBPSCl, using 4.2.3.2. A white powder was 
obtained, 416 mg. 
CP-MAS 13C NMR (101 MHz; None): δ 167.8 (C=O), 134.6, 131.2, 
127.9, 122.8 (Ar), 98.2 (C1), 82.0 (C4), 75.3 (C5), 69.7 (C3), 62.5 (C6), 
56.1 (C2), 26.5 (CH3). 
IR νmax(KBr): 3467 (O-H), 1778,1718 (C=O), 1193-968 (C-O) 1113, 874 
(Si-O) cm-1. 
II.17 starting with I.32 and TPSCl, using 4.2.3.2. A white powder was 
obtained, 462 mg. 
CP-MAS 13C NMR (101 MHz; None): δ 168.6 (C=O), 134.9, 130.5, 
128.1, 123.4 (Ar), 99.7 (C1), 82.0, 80.7 (C4), 74.5 (C5), 69.7 (C3), 60.5 
(C6), 55.6 (C2). IR νmax(KBr): 3448 (O-H), 1776, 1717 (C=O), 1196-997 
(C-O), 1118, 1095 (Si-O) cm-1. 
II.26 DPM starting with II.16 and TPSCl, using 4.2.3.2. A white 
powder was obtained, 433 mg of a white powder. 
IR νmax(KBr): 34448 (O-H), 1768, 1707 (C=O), 1102-998 (C-O), 
1117 (Si-O) cm-1. 
 
 
R1, R2 = DPM 
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 In this synthesis step was followed the same procedure as describe in 4.2.4. 
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II.21 starting with II.17 and 4 equiv. of S-2-Chloropropionic Acid. A 
yellow powder was obtained,  189 mg. 
IR νmax(KBr): 3382 (O-H), 1830, 1821 (C=O), 1748, 1726 (C=O), 
1598 (C-C Ar), 1090-996 (C-O), 1069 (Si-O) cm-1. 
II.18 starting with I.47 and 4 equiv. of S-2-Chloropropionic Acid. A 
yellow powder was obtained, 167 mg. 
IR νmax(KBr): 3432 (O-H), 1724, 1654 (C=O), 1554 (C-C Ar), 1093-
991 (C-O), 1113, 1053 (Si-O) cm-1. 
II.19 starting with I.47 and 2 equiv. of S-2-Chloropropionic Acid. A 
yellow powder was obtained, 179 mg. 
IR νmax(KBr): 3390 (O-H), 1716, 1655 (C=O), 1554 (C-C Ar), 1110-
998 (C-O), 1113, 1051 (Si-O) cm-1 
II.27 starting with II.26 and 2 equiv. of S-2-Chloropropionic Acid. A 
yellow powder was obtained, 149 mg. 
IR νmax(KBr): 3448 (O-H),  1768, 1708, 1664 (C=O), 1155-1032 (C-
O), 1117, 1072 (Si-O) cm-1. 
 
II.20 starting with II.17 and 2 equiv. of S-2-Chloropropionic Acid. 
A yellow powder was obtained, 178 mg. 
IR νmax(KBr): 3392(O-H), 1756, 1732 (C=O), 1593 (C-C Ar), 
1109-992 (C-O), 1081 (Si-O) cm-1. 
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4.2.3.2.2  Deprotection and N-acetylation  
4.2.3.2.2.1 Phthaloyl removal 
In order to remove the phthaloyl group the procedure described in 4.2.3.1.5.1, was 
used. 
4.2.3.2.2.2 N-acetylation 
 In order to acetylate all the amine groups the procedure described in 4.2.3.1.5.2, was 
used. 
4.2.3.2.2.3 Silyl group removal 
In order to remove all the silyl the procedure described in 4.2.3.1.5.3,was used. 
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Figure 4.10 Schematic representation of all deprotection reactions an N-acetylation 
II.22 starting with II.20 followed by the sequence of deprotection 
procedures 4.2.3.2.2. A yellow powder was obtained, 60 mg. 
IR νmax(KBr): 3435 (O-H), 1718, 1650 (C=O), 1158-998 (C-O) cm-1. 
II.23 starting with II.21 followed by the sequence of deprotection 
procedures 4.2.3.2.2. A yellow powder was obtained, 39 mg. 
Product was not characterized and was used directly in the enzymatic 
assays. 
 
II.24 starting with II.18 followed by the sequence of deprotection 
procedures 4.2.3.2.2. A yellow powder was obtained,  49 mg.  
Product was not characterized and was used directly in the enzymatic 
assays 
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4.2.4 Muramic Acid moiety insertion  
 
To a 200 mg of O3-free chitosan in 5 mL of anhydrous DMF was added NaH (152 mg, 
3.8 mmol) at 0ºC and was stirred for 1 hour. Then the S-2-Chloropropionic acid was added. 
The reaction was stirred from 0ºC to room temperature for 48 hours. Then the solvent was 
evaporated to dryness, and the product was diluted with 3 mL of distilled water and acidified 
with 1 M HCl to pH 3. The residues were washed with ethyl ether, 3 x 5 mL, and the aqueous 
layers were collected and the solvent was evaporated. The product obtained was dried under 
vacuum. 
4.2.5 N-acetylation 
To a solution of of N-free chitosan, add 20 equiv. of acetic anhydride in 2 mL of dried 
pyridine at 0ºC and let the temperature rise to room temperature over night. Then evaporate 
the solvent was evapoprated to dryness, washed with ethyl ether and 1 mL of distilled water 
and 0.1 mL of NaOH 1 M were added. The water was removed, and the residue obtained 
After that the precipitate was dissolved in 1 mL of distilled water and the pH adjusted to 3 with 
a solution of HCl 1 M. the water was removed to give the final product. 
4.3 General procedures to evaluate the final product 
4.3.1 Enzymatic digestion 
 
1. To an eppendorf tube the sample was added (10 mg/mL), in the respective buffer. 
The enzyme was added, lyzozime (10 mg/mL in ammonium acetate 40 mM, pH 5,25) 
1:0.225 (mg of sample: mg of enzyme) or mutanolysin 1:0.15 (mg of sample: µL of 
enzyme) (10 mg/mL in phosphate 25 mM, pH 5.5); 
2. The mixture was incubated for 24 or 92 hours at 37ºC 1.200 rpm in a eppendorf heat 
plaque; 
3. The mixture was boiled in water for 5 minutes; 
4. The samples were centrifuged at 13.000 rpm at room temperature for 5 minutes; 
5. The same volume of 0,5 M Borate Buffer pH 9.0 was added;  
6. Fresh 50 mg/mL NaBH4 was added in a ratio of 8.33:1 (mL of mixture: mL of 50 
mg/mL NaBH4) and incubated at room temperature for 2 hours;  
7. The sample pH was adjusted to 2.0 with 85% o-phosphoric acid; 
8. The samples were centrifuged at 13.000 rpm at room temperature for 5 minutes; 
9. The supernatant were collected and store at -20ºC. 
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II.25 starting with II.19 followed by the sequence of deprotection 
procedures 4.2.3.2.2. A yellow powder was obtained, 58 mg. 
Product was not characterized and was used directly in the enzymatic 
assays. 
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4.3.1.1 HPLC-UV protocol 
Table 4-2 HPLC UV protocol eluent composition 
Eluent 200 mM NaHPO4 pH 2.0 Mili-Q water Methanol (HPLC grade) 
A 1 L 900 mL 100 mL 
B 1 L 400 mL 600 mL 
 
The HPLC analyses were performed on a Shimadzu® prominence HPLC using a 
reverse phase C-18 Hypersil column Q = 0,5 mL/min; Oven at 52º C, the volume of injection 
was not fix and the eluting conditions applied are presented at Table 4-3. The detection was 
made by absorption at 206 and 280 nm. 
Table 4-3 Concentration gradient used during the HPLC-UV program 
Time (min) Solvent A% 
Solvent 
B% 
0 100 0 
155 0 100 
160 0 100 
175 100 0 
200 100 0 
  
All of the final products were analyzed through this program to check the outcome of 
the enzymatic hydrolysis. 
4.3.1.2 HPLC-MS protocol  
The HPLC analyses were performed on a Waters Alliance 2695 (Waters®, Ireland) 
equipped with a quaternary pump, solvent degasser, auto sampler and column oven, coupled 
to a Photodiode Array Detector Waters 996 PDA (Waters®, Ireland). The separation was 
performed on a reversed-phase column (LiCrospher® 100 RP-18, 250x4 mm; 5 µm; Merck®) 
at 35º C using an injection volume of 20 µL. The mobile phase consisted of Milli-Q water 
containing 0.5% formic acid (A): MeOH (B) at a flow rate of 0.30 mL/min and the eluting 
conditions applied are presented at Table 4-4. 
 
Figure 4.11 HPLC-UV eluent profile 
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Table 4-4 Concentration gradient used during the HPLC-MS program  
Time (min) Solvent %A Solvent %B 
0.00 100.0 0.0 
30.00 0.0 100.0 
50.00 0.0 100.0 
60.00 100.0 0.0 
80.00 100.0 0.0 
 
Photodiode Array Detector Waters 2996 (Waters®, Ireland) was use to scan 
wavelength absorption from 205 to 400 nm. MS/MS experiments were performed on 
Micromass® Quattro Micro triple quadrupole (Waters®, Ireland) with an electrospray in 
positive ion mode (ESI+), with ion source at 120º C, capillary voltage of 3.0 kV and source 
voltage of 30V. The compounds were ionized and spectra of the column eluent were recorded 
in the range m/z 100-2000. High purity nitrogen (N2) was used both as drying gas and as a 
nebulising gas. MassLynx software (version 4.1) was used for data acquisition and 
processing. 
 
4.3.2 mCherry-PGRP pull-down assay 
The mCherry-PGRP-SA was quantified in the Nanodrop, using PBS Buffer as blank; 
Blanks: 
 A: 20 µL of PGN (10 mg/mL) centrifuged at 13.000 rpm for 5 minutes, pellet was 
disposed.   
 B: 20 µL of PGN (10 mg/mL) digested with amidase LytA overnight with the protocol 
4.3.1, pellet was disposed. 
 C: 20 µL of PGN (10 mg/mL) digested with muramidase, Mutanolysin, overnight with 
protocol 4.3.1, pellet was disposed.  
 D: 20 µL of PGN (10 mg/mL) digested with muramidase, Mutanolysin, overnight with 
protocol 4.3.1 and digest with amidase LytA overnight with the protocol 4.3.1, pellet was 
disposed.  
Reaction mixture: 
1. 25 µL of BSA 30x (from NEB) – use a master solution;  
2. 20 µL of PGN (10 mg/mL) – only in some assays; 
3. mCherry-PGRP-SA to 0,3 mg/mL final concentration;  
4. Buffer to 300 µL final volume.  For each different Protein:Buffer pair tested prepared 
an empty control;  
5. Use 20 µL of MilliQ water instead of PGN;  
6. Incubated 30 minutes at 25ºC at 1000 rpm;  
7. Centrifuged 10 minutes at 3000 rpm;  
8. Collected 30 µL of the supernatant and mix it with 30 µL of Loading Buffer at 2x – 
Unbound Fraction;  
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9. Ressuspend the pellet in 300 µL of Buffer and centrifuge for 5 minutes at 6000 rpm;  
10. Ressuspend the pellet in 300 µL of Buffer and centrifuge for 2 minutes at 132000 
rpm;  
11. Ressupend the pellet in 30 µL of Loading Buffer at 1x – Bound Fraction;  
12. Apply in an electrophoresis gel both bound and unbound fraction.  
4.3.2.1 Electrophoresis 
Gel preparation was performed according to Table 4-5. The samples were prepared 
by adding loading buffer, Table 4-6, containing β‐mercaptoethanol in a 1:1 ratio to the sample 
and boiling them for 5 min, being then immediately applied onto the gel. The gels were ran for 
1 h 30 min at a fix voltage 80V in 1x Tris‐Glycine buffer, Table 4-7. The samples were 
prepared in the exact same way as mentioned above. 
 
 
Table 4-5 SDS gel composition 
 Running gel 8.0% - 10 mL Stacking gel 4.0%  6 mL 
Acrilamide 2.7 mL 0.8 mL 
Tris-HCl, 1.5 M, pH 8.8 2.5 mL ---- 
Tris-HCl, 0.5 M pH 6.8 ---- 1.5 mL 
SDS 10% (w/v) 0.1 mL 60 µL 
ddH2O 4.65 mL 3.6 mL 
TMED 5 µL 6 µL 
PSA 10% (w/v) 50 µL 30 µL 
 
Table 4-6 Loading Buffer 
Reagent Volume (mL) 
SDS 10% (w/v) 1.0 
Glycerol 0.5 
Tris 1M pH 6.8 0.8 
Bromophenol blue 0.2% (w/v) 0.1 
β-Mercaptoethanol 0.5 
ddH2O 2.1 
 
Table 4-7 Electrophoresis Buffer 
Reagent Concentration 
Tris base 0.025 M, pH 8.8 
Glycine 0.102 M 
SDS 0.1 % (w/v) 
 
4.3.3 Monosaccharide composition analysis 
1. A master solution of HCl was prepared, containing 37.25 µL HCl 37% (12 M) and 
92.75 µL H2O per sample;  
2. To a 1.5 mL eppendorf was added 20 µL of the sample at 10 mg/mL (0.2 mg PGN 
total) and 130 µL of the HCl master solution. Final volume of 150 µL at 3 M HCl;  
3. The mixture was transfered to a reaction vial and incubated at 95ºC for 2 hours;  
4. The reaction mixture was transferred into a punctured 1.5 mL Eppendorf;  
5. The reaction vial was washed with 100 µL of MilliQ H2O and added to the Eppendorf;  
6. The mixture was lyophilized until completely dryness; 
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7. Ressuspended in 500 µL of MilliQ H2O;  
8. Lyophilized overnight;  
9. The pellet was suspended in 150 µL of MilliQ H2O before injection and apply 10 µL.    
 The anionic exchange chromatography analyses were performed on an ICS-5000 Ion 
Chromatography Systems – Dionex (Thermo Scientific®), and the eluting conditions applied 
are presented at Table 4-8. 
 
Table 4-8 Concentration gradient used during the anionic exchange chromatography program 
Time 
(min) 
Flow 
(mL/min) 
Eluent % 
B C D 
0 1 1,8 0 0 
20 1 1,8 0 0 
25 1 1,8 0 20 
30 1 1,8 0 20 
35 1 1,8 0 80 
40 1 1,8 0 80 
45 1 1,8 0 0 
50 1 1,8 0 0 
55 1 1,8 0 0 
60 1 1,8 0 0 
 
Table 4-9 Eluent Composition 
Eluent Composition 
A MilliQ H2O 
B 1M NaOH (Ion Chromatography Grade) 
C Mili-Q H2O 
D 1M NaCH3COO (HPLC Grade) 
  
Figure 4.12 Eluent profile for the anionic exchange chromatography   
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